var title_f20_34_21024="Pleural plaques CT";
var content_f20_34_21024=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F61458&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F61458&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bilateral pleural plaques",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 357px; height: 339px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CT scan shows nodular and flat foci of pleural thickening that are present bilaterally. Flecks of calcium are noted within the plaques.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_34_21024=[""].join("\n");
var outline_f20_34_21024=null;
var title_f20_34_21025="Regulation sarcolemma function";
var content_f20_34_21025=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F53118&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F53118&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 583px\">",
"   <div class=\"ttl\">",
"    Regulation of the calcium transient at the sarcolemma membrane",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 563px; height: 348px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic representation of the regulation of the calcium transient at the sarcolemma membrane. Calcium moves across the sarcolemma via the sodium-calcium exchanger (which uses the favorable electrochemical gradient for sodium to drive passive calcium transport) and the L-type calcium channel. Hormones and drugs that can affect this process include digoxin (which inhibits the Na-K-ATPase pump), epinephrine and isoproterenol (which bind the the beta receptor and activate adenylyl cyclase, leading to the formation of cyclic AMP), epinephrine and phenylephrine (which bind to the alpha receptor and activate phospholipase C), and milrinone and the methylxanthines (which are phosphodiesterase inhibitors, thereby slowing the metabolism of cyclic AMP and prolonging the beta adrenergic effect).",
"    <div class=\"footnotes\">",
"     DAG: diacylglycerol; IP3: inositol triphosphate.",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Timothy W Smith, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_34_21025=[""].join("\n");
var outline_f20_34_21025=null;
var title_f20_34_21026="Oblique fracture of the fifth metatarsal shaft";
var content_f20_34_21026=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F59161&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F59161&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Oblique fracture of the fifth metatarsal shaft",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 319px; height: 406px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An oblique fracture (arrow) of the distal shaft of the fifth metatarsal is seen in two plain radiographs, one using an anteroposterior view (left side image) and the other an oblique view (right side image) of the foot.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Eiff MP, Hatch RL, Calmbach WL. Fracture management for primary care, 2nd ed. Chapter 2: General principles of fracture care. Saunders, Philadelphia 1998. Illustration used with permission of Elsevier Inc. All rights reserved. Copyright &copy; 1998 Elsevier Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_34_21026=[""].join("\n");
var outline_f20_34_21026=null;
var title_f20_34_21027="Patient information: Chest pain (The Basics)";
var content_f20_34_21027=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/15332\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?1/15/1268\">",
"         Heart attack symptoms",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?38/24/39298\">",
"         Patient information: Angioplasty and stenting for the heart (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?34/53/35667\">",
"         Patient information: Cardiac catheterization (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?27/10/27809\">",
"         Patient information: Coronary heart disease (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?6/54/7012\">",
"         Patient information: Coronary heart disease in women (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?24/51/25395\">",
"         Patient information: ECG and stress test (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?24/13/24787\">",
"         Patient information: Echocardiogram (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?21/27/21940\">",
"         Patient information: Medicines after a heart attack (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?31/30/32226\">",
"         Patient information: Nuclear heart testing (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?35/6/35938\">",
"         Patient information: Stress-induced cardiomyopathy (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?30/14/30946\">",
"         Patient information: Treatment choices for angina (chest pain) (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?31/1/31766\">",
"         Patient information: Angina treatment &mdash; medical therapy (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?42/10/43170\">",
"         Patient information: Angina treatment &mdash; medical versus interventional therapy (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?42/9/43157\">",
"         Patient information: Chest pain (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Chest pain (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/chest-pain-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H26441468\">",
"      <span class=\"h1\">",
"       Should I call 9-1-1 for an ambulance if I have chest pain?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You should call 9-1-1 if the pain:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Is new or severe",
"       </li>",
"       <li>",
"        Happens along with shortness of breath",
"       </li>",
"       <li>",
"        Lasts more than a few minutes",
"       </li>",
"       <li>",
"        Gets worse when you walk, climb stairs, or do other types of physical activity",
"       </li>",
"       <li>",
"        Scares or worries you",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Having chest pain does not necessarily mean you are having a heart attack. Most people who go to the emergency room with chest pain are",
"      <strong>",
"       not",
"      </strong>",
"      having a heart attack. Their pain is usually caused by less serious problems, such as muscle pain or heartburn. Even so, you should not take any chances.",
"     </p>",
"     <p>",
"      People often delay seeking help for a heart attack because they think the symptoms are not serious or will go away. When they do that, they risk permanent damage to their heart&mdash;or even death.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H26441475\">",
"      <span class=\"h1\">",
"       Is chest pain the only important symptom of a heart attack?",
"      </span>",
"      &nbsp;&mdash;&nbsp;No. Other symptoms are important, too. Sometimes people do not go to the hospital because they do not have any pain at all. But it is possible to have a heart attack without pain. This is more likely in women, people with diabetes, and people older than 60.",
"     </p>",
"     <p>",
"      It is important to pay attention to any of the symptoms of a heart attack, (",
"      <a class=\"graphic graphic_figure graphicRef52579 \" href=\"UTD.htm?1/15/1268\">",
"       figure 1",
"      </a>",
"      ), which can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Pain, pressure, or discomfort in the center of the chest",
"       </li>",
"       <li>",
"        Pain, tingling, or discomfort in other parts of the upper body, including the arms, back, neck, jaw, or stomach",
"       </li>",
"       <li>",
"        Shortness of breath",
"       </li>",
"       <li>",
"        Nausea, vomiting, burping, or heartburn",
"       </li>",
"       <li>",
"        Sweating or having cold, clammy skin",
"       </li>",
"       <li>",
"        A racing or uneven heart rate",
"       </li>",
"       <li>",
"        Feeling dizzy or lightheaded or even fainting",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      These symptoms are important if they last more than a few minutes or keep happening over and over (coming and going). If you think you may be having a heart attack, call 9-1-1 right away. Do not try to get to the hospital on your own.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H26441482\">",
"      <span class=\"h1\">",
"       Is heart attack the only cause of chest pain?",
"      </span>",
"      &nbsp;&mdash;&nbsp;No. Chest pain can be caused by lots of other problems, including:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Heart problems other than heart attacks, such as infection around the heart",
"       </li>",
"       <li>",
"        Muscle soreness after an activity that involves the chest muscles",
"       </li>",
"       <li>",
"        Diseases that cause pain, such as arthritis",
"       </li>",
"       <li>",
"        Shingles (herpes zoster), a condition linked to the chickenpox virus that also causes a painful rash",
"       </li>",
"       <li>",
"        Any kind of injury to the chest, including surgery",
"       </li>",
"       <li>",
"        Digestive problems such as heartburn, acid reflux, stomach ulcers, or irritable bowel syndrome",
"       </li>",
"       <li>",
"        Problems affecting the lungs, such as pneumonia (an infection in the lungs) or blood clots in the lungs",
"       </li>",
"       <li>",
"        Psychological problems, such as panic disorder or depression",
"       </li>",
"       <li>",
"        Weakening of the lining of the big blood vessel in the chest (the aorta)",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H26441489\">",
"      <span class=\"h1\">",
"       What will happen if I go to the emergency room?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The people treating you in the emergency room will examine you and then run tests to try to find the cause of your pain. But don&rsquo;t be surprised if you do not find out right away why you have pain. The cause of chest pain is not always easy to find. Even so, doctors can usually tell if your heart is in trouble.",
"     </p>",
"     <p>",
"      The tests you might have include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <strong>",
"         An electrocardiogram (ECG or EKG)",
"        </strong>",
"        &mdash; This test measures the electrical activity in your heart. It can help doctors find out if you are having a heart attack.",
"       </li>",
"       <li>",
"        <strong>",
"         Blood tests",
"        </strong>",
"        &mdash; During a heart attack, the heart releases certain chemicals. If these chemicals are in your blood, it might mean you are having a heart attack.",
"       </li>",
"       <li>",
"        <strong>",
"         A stress test",
"        </strong>",
"        &mdash; During a stress test, you might be asked to run or walk on a treadmill while you also have an ECG. Physical activity increases the heart&rsquo;s need for blood. This test helps doctors see if the heart is getting enough blood. If you cannot walk or run, your doctor might do this test by giving you a medicine to make your heart pump faster.",
"       </li>",
"       <li>",
"        <strong>",
"         Cardiac catheterization",
"        </strong>",
"        &mdash; Cardiac (heart) catheterization is also known as cardiac &ldquo;cath&rdquo; or coronary angiography. During this test the doctor inserts a thin tube into a large artery in your leg or arm and advances it to your heart. Then the doctor injects a dye that shows up on an x-ray. This dye can show whether any of the arteries in your heart is clogged.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H26441496\">",
"      <span class=\"h1\">",
"       What if I am having a heart attack?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you are having a heart attack, the doctor will give you treatments to reduce the damage to your heart and relieve your pain. These treatments include pills, medicines that go right into a vein (through an &ldquo;IV&rdquo;), and possibly a treatment called &ldquo;angioplasty.&rdquo; During angioplasty, a doctor puts a thin tube into a blood vessel in the leg or arm and advances it to the heart. Then the doctor inflates a tiny balloon inside the clogged artery to reopen it. Often the doctor props open the artery using a tiny mesh tube called a stent.",
"     </p>",
"     <p>",
"      The sooner you get treated for a heart attack, the better treatment will work. Every minute counts when it comes to keeping your heart muscle alive!",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H26441503\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?21/27/21940?source=see_link\">",
"       Patient information: Medicines after a heart attack (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?27/10/27809?source=see_link\">",
"       Patient information: Coronary heart disease (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?24/51/25395?source=see_link\">",
"       Patient information: ECG and stress test (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?24/13/24787?source=see_link\">",
"       Patient information: Echocardiogram (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?31/30/32226?source=see_link\">",
"       Patient information: Nuclear heart testing (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?34/53/35667?source=see_link\">",
"       Patient information: Cardiac catheterization (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?6/54/7012?source=see_link\">",
"       Patient information: Coronary heart disease in women (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?38/24/39298?source=see_link\">",
"       Patient information: Angioplasty and stenting for the heart (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?30/14/30946?source=see_link\">",
"       Patient information: Treatment choices for angina (chest pain) (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?35/6/35938?source=see_link\">",
"       Patient information: Stress-induced cardiomyopathy (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?31/1/31766?source=see_link\">",
"       Patient information: Angina treatment &mdash; medical therapy (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?42/10/43170?source=see_link\">",
"       Patient information: Angina treatment &mdash; medical versus interventional therapy (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?42/9/43157?source=see_link\">",
"       Patient information: Chest pain (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?20/34/21027?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15332 Version 7.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-122.72.76.133-94E968098A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_34_21027=[""].join("\n");
var outline_f20_34_21027=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26441468\">",
"      Should I call 9-1-1 for an ambulance if I have chest pain?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26441475\">",
"      Is chest pain the only important symptom of a heart attack?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26441482\">",
"      Is heart attack the only cause of chest pain?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26441489\">",
"      What will happen if I go to the emergency room?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26441496\">",
"      What if I am having a heart attack?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26441503\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/15332\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?1/15/1268\">",
"      Heart attack symptoms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?31/1/31766?source=related_link\">",
"      Patient information: Angina treatment &mdash; medical therapy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?42/10/43170?source=related_link\">",
"      Patient information: Angina treatment &mdash; medical versus interventional therapy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?38/24/39298?source=related_link\">",
"      Patient information: Angioplasty and stenting for the heart (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?34/53/35667?source=related_link\">",
"      Patient information: Cardiac catheterization (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?42/9/43157?source=related_link\">",
"      Patient information: Chest pain (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/10/27809?source=related_link\">",
"      Patient information: Coronary heart disease (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?6/54/7012?source=related_link\">",
"      Patient information: Coronary heart disease in women (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?24/51/25395?source=related_link\">",
"      Patient information: ECG and stress test (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?24/13/24787?source=related_link\">",
"      Patient information: Echocardiogram (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?21/27/21940?source=related_link\">",
"      Patient information: Medicines after a heart attack (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?31/30/32226?source=related_link\">",
"      Patient information: Nuclear heart testing (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/6/35938?source=related_link\">",
"      Patient information: Stress-induced cardiomyopathy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?30/14/30946?source=related_link\">",
"      Patient information: Treatment choices for angina (chest pain) (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f20_34_21028="Inferior shoulder dislocation reduction";
var content_f20_34_21028=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F50866&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F50866&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Inferior shoulder dislocation reduction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 401px; height: 373px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The traction-countertraction approach is employed to reduce inferior dislocations. Forces are aligned with the abducted arm.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Scott C Sherman, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_34_21028=[""].join("\n");
var outline_f20_34_21028=null;
var title_f20_34_21029="Saquinavir: Patient drug information";
var content_f20_34_21029=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Saquinavir: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/25/3482?source=see_link\">",
"     see \"Saquinavir: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/19/37177?source=see_link\">",
"     see \"Saquinavir: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F219647\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Invirase&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F219648\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Invirase&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10028347\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10028349\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691895",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat HIV infection.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10028348\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702905",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to saquinavir or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2935539",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Low magnesium, low potassium, very bad liver disease, or a slow heartbeat without a working pacemaker.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705251",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a long QT on ECG.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701018",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are",
"       <b>",
"        not",
"       </b>",
"       taking ritonavir.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10028353\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696820",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not run out of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697797",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may have some heart tests before starting this drug. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697207",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), this drug may sometimes raise blood sugar. Talk with your doctor about how to fine tune this.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697262",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have hemophilia, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696900",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take St John's wort with this drug. This drug may not work as well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697712",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To protect from diseases caused by having sex, use a latex condom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697729",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy in HIV disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696918",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use a hormone-related kind of birth control.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696711",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not breast-feed if you have HIV disease unless your doctor tells you to.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10028354\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697889",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain or heartburn.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697937",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in body fat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698138",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       High blood sugar may cause diabetes while on this drug. This most often goes back to normal when this drug is stopped.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10028356\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698966",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Unsafe or slow heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698963",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       More trips to the bathroom, more thirst, or weight loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10028351\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695921",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take within 2 hours of a high-fat meal.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10028352\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696559",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose, brand, or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10028357\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10028358\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11040 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.234.146.186-562547D45F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_34_21029=[""].join("\n");
var outline_f20_34_21029=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F219647\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F219648\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028347\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028349\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028348\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028353\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028354\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028356\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028351\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028352\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028357\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028358\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?3/25/3482?source=related_link\">",
"      Saquinavir: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/19/37177?source=related_link\">",
"      Saquinavir: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f20_34_21030="Pityriasis rosea drk skin 3";
var content_f20_34_21030=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F71058&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F71058&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pityriasis rosea",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 302px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The individual lesions of pityriasis rosea often appear as elongated maculopapules with a rough surface.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Fleisher, GR, Ludwig, S, Baskin, MN. Atlas of Pediatric Emergency Medicine, Lippincott Williams &amp; Wilkins, Philadelphia 2004. Copyright &copy; 2004 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_34_21030=[""].join("\n");
var outline_f20_34_21030=null;
var title_f20_34_21031="Prognosis and treatment of dementia with Lewy bodies";
var content_f20_34_21031=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Prognosis and treatment of dementia with Lewy bodies",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/34/21031/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/34/21031/contributors\">",
"     Ann Marie Hake, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/34/21031/contributors\">",
"     Martin R Farlow, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/34/21031/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/34/21031/contributors\">",
"     Steven T DeKosky, MD, FAAN",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/34/21031/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/34/21031/contributors\">",
"     April F Eichler, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?20/34/21031/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 6, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dementia with Lewy bodies (DLB) is increasingly recognized clinically as the second most common type of degenerative dementia after Alzheimer disease (AD). In addition to dementia, distinctive clinical features include: visual hallucinations, parkinsonism, cognitive fluctuations, dysautonomia, sleep disorders, and neuroleptic sensitivity.",
"   </p>",
"   <p>",
"    First described in the 1960s, DLB has a varied clinical presentation that shares features with other degenerative dementias. It was often overlooked pathologically because of the difficulty in identifying cortical Lewy bodies. With the advent of immunohistochemical stains for constituents of Lewy bodies, the prevalence of this disorder began to be recognized. However, challenges remain in defining this as a distinct entity from other degenerative dementias.",
"   </p>",
"   <p>",
"    There is some clinical imperative to diagnose DLB, as optimal treatment choices - for best efficacy and limitation of significant side effects - are specific to DLB. However, DLB continues to be under recognized, and the clinical diagnostic criteria continue to be refined to improve specificity and sensitivity.",
"   </p>",
"   <p>",
"    This article will describe the prognosis and treatment of dementia with Lewy bodies. The epidemiology, neuropathology, pathogenesis, clinical features, and diagnosis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/41/34455?source=see_link\">",
"     \"Epidemiology, pathology, and pathogenesis of dementia with Lewy bodies\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1914?source=see_link\">",
"     \"Clinical features and diagnosis of dementia with Lewy bodies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The treatment of other dementia syndromes and the treatment of dementia in general are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1913?source=see_link\">",
"     \"Cholinesterase inhibitors in the treatment of dementia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/4/33865?source=see_link\">",
"     \"Treatment of dementia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27402?source=see_link\">",
"     \"Treatment of behavioral symptoms related to dementia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/36/15946?source=see_link\">",
"     \"Parkinson disease dementia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/25/408?source=see_link\">",
"     \"Frontotemporal dementia: Treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/55/10104?source=see_link\">",
"     \"Treatment and prevention of vascular dementia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;As with all of the degenerative dementias, cognitive decline in dementia with Lewy bodies (DLB) progresses inexorably to death. Psychotic symptoms, particularly visual hallucinations, tend to persist in patients with DLB [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21031/abstract/1\">",
"     1",
"    </a>",
"    ]. Parkinsonism also worsens over time, especially in patients for whom this is an early feature [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21031/abstract/2\">",
"     2",
"    </a>",
"    ]. In one retrospective series, individuals with impairment of visuospatial skill on baseline neuropsychological testing had a faster rate of clinical decline compared with those who did not [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21031/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While some have reported that the rates of cognitive decline are similar for Alzheimer disease (AD) and DLB [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21031/abstract/4-7\">",
"     4-7",
"    </a>",
"    ], others report a more stable course for DLB [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21031/abstract/8\">",
"     8",
"    </a>",
"    ], and others have found a faster rate of cognitive decline in DLB [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21031/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. In one series, patients with DLB lost an average of 5.8 points per year on Mini Mental State Examination (MMSE) compared with 4.1 points for AD [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21031/abstract/9\">",
"     9",
"    </a>",
"    ]. In this study, survival time in DLB was also shorter than in AD: 7.7 years versus 9.3 years since onset of cognitive symptoms, a finding corroborated in another cohort of patients with AD and DLB [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21031/abstract/11\">",
"     11",
"    </a>",
"    ]. The degree of motor parkinsonism and psychiatry symptoms appear to contribute to the increased mortality. In another study, while survival times were similar in AD and DLB, patients with DLB were institutionalized earlier, perhaps in relationship to earlier development of parkinsonism and daytime somnolence [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21031/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of Dementia with Lewy bodies (DLB) is symptomatic, targeted toward specific disease manifestations, and based upon somewhat limited evidence. There are no treatments with evidence of disease-modifying effects.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     General strategies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because medications may be poorly tolerated in DLB, nonpharmacologic, behavioral strategies aimed at modifying stressors in the environment should be employed whenever possible. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27402?source=see_link&amp;anchor=H11#H11\">",
"     \"Treatment of behavioral symptoms related to dementia\", section on 'Nonpharmacologic management'",
"    </a>",
"    .) Physical therapy and mobility aids may help in the management of parkinsonism.(See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/11/4277?source=see_link\">",
"     \"Nonpharmacologic management of Parkinson disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patient and caregiver education regarding risks, benefits, and limitations of treatments is important. In many cases, treatment choices represent a trade-off between parkinsonism and psychosis, and the relative preferences of the patient and caregiver will be decisive.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7685079\">",
"    <span class=\"h2\">",
"     Cognition and neuropsychiatric disturbances",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Cholinesterase inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cholinesterase inhibitors may represent a first line pharmacologic treatment in DLB, although the evidence is as yet somewhat limited [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21031/abstract/13\">",
"     13",
"    </a>",
"    ]. While cholinesterase inhibitors were initially developed for Alzheimer disease (AD), the evidence suggests that cholinergic deficits are even greater in DLB. Multiple anecdotal reports [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21031/abstract/14,15\">",
"     14,15",
"    </a>",
"    ], open-label studies [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21031/abstract/16-18\">",
"     16-18",
"    </a>",
"    ], and two randomized, controlled trials [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21031/abstract/19,20\">",
"     19,20",
"    </a>",
"    ] suggest that cholinesterase inhibitors are efficacious in DLB, with reported benefit not only in cognition, but also for fluctuations, psychotic symptoms, and parkinsonian symptoms. In some instances, the response has been dramatic, but temporary. The effect size has been reported to be larger than that in patients with AD [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21031/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A multicenter study randomly assigned 120 patients with DLB to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/26/6567?source=see_link\">",
"     rivastigmine",
"    </a>",
"    (6 to 12 mg per day) or placebo for 20 weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21031/abstract/19\">",
"     19",
"    </a>",
"    ]. Patients on rivastigmine showed significantly reduced anxiety, delusions, and hallucinations, and had significantly better performance on a computerized battery of neuropsychological tests, especially tasks requiring sustained attention. The differences between rivastigmine and placebo disappeared after drug discontinuation. The expected gastrointestinal side effects as well as hypersalivation, lacrimation, and urinary frequency were seen with a higher frequency in the rivastigmine group, but the drug was well tolerated overall. Another randomized study found that 12 weeks of therapy with either 5 mg or 10 mg of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/30/10726?source=see_link\">",
"     donepezil",
"    </a>",
"    was associated with significant improvements in cognitive and behavioral measures, as well as caregiver burden when compared to placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21031/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While not reported in the randomized studies as significant risks, there have been case reports of worsening cognitive function, REM sleep disorder, or parkinsonism with cholinesterase inhibitors [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21031/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]; patients should be monitored carefully while using these drugs. Cholinesterase inhibitors also have demonstrated mild to moderate benefits in Parkinson disease dementia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/36/15946?source=see_link&amp;anchor=H25#H25\">",
"     \"Parkinson disease dementia\", section on 'Cholinesterase inhibitors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is possible that cholinesterase inhibitors may affect disease progression as well as ameliorate symptoms. In one autopsy cohort of 24 patients with DLB, blinded pathologic assessments found that patients treated with cholinesterase inhibitors had a lower beta-amyloid plaque burden compared to untreated patients [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21031/abstract/24\">",
"     24",
"    </a>",
"    ]. However, it is not clear if either treatment or plaque burden was associated with the degree of clinical disease progression.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7685485\">",
"    <span class=\"h3\">",
"     Memantine",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/16/24837?source=see_link\">",
"     Memantine",
"    </a>",
"    has reported efficacy in moderate to severe Alzheimer disease and vascular dementia. A randomized controlled trial of 72 patients with either DLB or Parkinson disease dementia found that patients treated with memantine for 24 weeks performed better on the primary outcome assessment measure, the clinical global impression of change, but not on most of the other secondary outcome measures [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21031/abstract/25\">",
"     25",
"    </a>",
"    ]. In a subsequent 24-week trial that compared memantine to placebo in 199 patients with either DLB or Parkinson disease dementia, the subset of 75 patients with DLB (but not PDD or the group overall) demonstrated improved outcome on the same primary outcome measure, but again not on most secondary outcome measures [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21031/abstract/26\">",
"     26",
"    </a>",
"    ]. In both of these studies, memantine was well-tolerated. However, some other studies have noted that worsening of delusions and hallucinations with memantine may be particularly problematic in patients with DLB [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21031/abstract/27,28\">",
"     27,28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7685558\">",
"    <span class=\"h3\">",
"     REM sleep disorder",
"    </span>",
"    &nbsp;&mdash;&nbsp;REM sleep disorder often responds to low doses of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/45/26328?source=see_link\">",
"     clonazepam",
"    </a>",
"    (0.25 to 1.5 mg) or melatonin (3 to 12 mg) given at bedtime [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21031/abstract/29-31\">",
"     29-31",
"    </a>",
"    ]. Melatonin may be preferred in the setting of cognitive impairment.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/56/20361?source=see_link\">",
"     Quetiapine",
"    </a>",
"    (12.5 mg) may also be successful, but is probably a third choice in this population.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Neuroleptics",
"    </span>",
"    &nbsp;&mdash;&nbsp;The potential for severe neuroleptic sensitivity reactions, including exacerbation of parkinsonism, confusion, or autonomic dysfunction, limits the usefulness of neuroleptic medications in DLB (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1914?source=see_link&amp;anchor=H10#H10\">",
"     \"Clinical features and diagnosis of dementia with Lewy bodies\", section on 'Neuroleptic sensitivity'",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    If a patient experiences severe, disabling psychosis, a trial of a cholinesterase inhibitor",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    lowering the dose of antiparkinson medication should be considered first. Randomized, placebo-controlled studies suggest that antipsychotic agents have limited efficacy in patients with dementia in general and in DLB in particular [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21031/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27402?source=see_link\">",
"     \"Treatment of behavioral symptoms related to dementia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If antipsychotic therapy is required, only atypical neuroleptics, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/36/37449?source=see_link\">",
"     olanzapine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/56/20361?source=see_link\">",
"     quetiapine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/39/4728?source=see_link\">",
"     ziprasidone",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/11/43193?source=see_link\">",
"     aripiprazole",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/43/44728?source=see_link\">",
"     paliperidone",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/33/11802?source=see_link\">",
"     risperidone",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/21/35161?source=see_link\">",
"     clozapine",
"    </a>",
"    should be used in very small doses in order to reduce the risk of severe reaction [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21031/abstract/33-36\">",
"     33-36",
"    </a>",
"    ]. Patients and caregivers should be warned about the possibility of severe side effects. In addition to neuroleptic sensitivity reactions more specific to DLB, these drugs are associated with an increased risk of death when used in elderly patients with dementia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27402?source=see_link&amp;anchor=H15#H15\">",
"     \"Treatment of behavioral symptoms related to dementia\", section on 'Serious adverse events'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/10/15530?source=see_link&amp;anchor=H76524651#H76524651\">",
"     \"Second-generation antipsychotic medications: Pharmacology, administration, and comparative side effects\", section on 'Side effects'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If the desired clinical response is not seen from one agent, it should be discontinued and another agent tried, rather than escalating the dose of the first agent. If",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/21/35161?source=see_link\">",
"     clozapine",
"    </a>",
"    is used, frequent blood counts must be obtained to monitor for agranulocytosis. The older, conventional antipsychotics should be avoided entirely [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21031/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7685205\">",
"    <span class=\"h3\">",
"     Other psychotropic medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;There have been no systematic studies of the use of antidepressants, anxiolytics, benzodiazepines, or anticonvulsants in the treatment of the behavioral and psychiatric symptoms in DLB [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21031/abstract/4\">",
"     4",
"    </a>",
"    ]. Selective serotonin reuptake inhibitors are commonly used in the treatment of depression. Benzodiazepines are generally AVOIDED (except for REM sleep disorder), especially for long term use, because of the potential for worsening confusion, gait disorder, and paradoxical agitation. Tricyclic agents are AVOIDED because of their anticholinergic properties. Electroconvulsive therapy has been successfully employed in depressed patients with DLB [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21031/abstract/37\">",
"     37",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27402?source=see_link\">",
"     \"Treatment of behavioral symptoms related to dementia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Antiparkinson medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of parkinsonian symptoms in DLB is similar to that for Parkinson disease (PD), if somewhat less successful [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21031/abstract/38-40\">",
"     38-40",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/63/32762?source=see_link&amp;anchor=H2#H2\">",
"     \"Pharmacologic treatment of Parkinson disease\", section on 'Symptomatic therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is concern that these medications may exacerbate psychotic symptoms in DLB, but our clinical experience and small case series suggest that by using a conservative approach - small doses and slow upward titration - these agents are generally effective and well tolerated [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21031/abstract/23,41\">",
"     23,41",
"    </a>",
"    ]. Worsening of psychotic symptoms and REM sleep disorder may require addition of a small dose of an atypical neuroleptic [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21031/abstract/41,42\">",
"     41,42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Levodopa seems to be more effective than dopamine agonists and produces fewer side effects [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21031/abstract/43\">",
"     43",
"    </a>",
"    ]. A suggested initial dose is one-half tablet of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/36/36423?source=see_link\">",
"     carbidopa-levodopa",
"    </a>",
"    (Sinemet)",
"    <span class=\"nowrap\">",
"     25/100",
"    </span>",
"    mg three times daily, titrated upward over several weeks as tolerated and according to the clinical response. Anticholinergic agents are generally avoided in DLB because they may worsen cognitive function.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7685065\">",
"    <span class=\"h2\">",
"     Orthostatic hypotension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medical therapy can improve symptoms of orthostatic hypotension in most DLB patients [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21031/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. We have used",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/9/21655?source=see_link\">",
"     fludrocortisone",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/35/2613?source=see_link\">",
"     midodrine",
"    </a>",
"    , and a combination of the two successfully in several of our patients. Anticholinergic agents for the treatment of urinary incontinence should probably be avoided in DLB patients who have orthostatic hypotension. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/2/5161?source=see_link\">",
"     \"Treatment of orthostatic and postprandial hypotension\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?18/3/18482?source=see_link\">",
"       \"Patient information: Dementia with Lewy bodies (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?14/37/14934?source=see_link\">",
"       \"Patient information: Dementia (including Alzheimer disease) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dementia with Lewy bodies (DLB) is the second most common form of degenerative dementia after Alzheimer disease.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      DLB is characterized clinically by deficits in attention and visuospatial function; fluctuating cognition; recurrent visual hallucinations; and spontaneous motor features of parkinsonism. Other associated symptoms include repeated falls, syncope, autonomic dysfunction, neuroleptic sensitivity, delusions, hallucinations in other modalities, sleep disorders, and depression. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1914?source=see_link\">",
"       \"Clinical features and diagnosis of dementia with Lewy bodies\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Nonpharmacologic, behavioral therapies, when appropriate, are preferred over medications, which have a high rate of adverse effects. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27402?source=see_link&amp;anchor=H11#H11\">",
"       \"Treatment of behavioral symptoms related to dementia\", section on 'Nonpharmacologic management'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      We recommend a treatment trial with cholinesterase inhibitors (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/26/6567?source=see_link\">",
"       rivastigmine",
"      </a>",
"      9.5 mg per day given by transdermal patch or 6 to 12 mg per day given orally) to ameliorate cognitive and behavioral symptoms in patients with DLB (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Cholinesterase inhibitors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If disabling psychotic symptoms persist after initiating treatment with cholinesterase inhibitors, we suggest cautious addition of a very low dose atypical neuroleptic agent (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/56/20361?source=see_link\">",
"       quetiapine",
"      </a>",
"      12.5 mg per day) after informing patients and caregivers of the risks, including the development of severe neuroleptic sensitivity reactions (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Neuroleptics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest starting levodopa for treatment of disabling parkinsonism (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Low doses and slow upward titration with monitoring for increased psychosis is advised (eg, one-half tablet of Sinemet",
"      <span class=\"nowrap\">",
"       25/100",
"      </span>",
"      mg three times daily, titrated upward over several weeks as tolerated and according to the response). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Antiparkinson medications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest the use of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/45/26328?source=see_link\">",
"       clonazepam",
"      </a>",
"      (0.25 mg) or melatonin (3 mg) given at bedtime for patients with REM sleep disorder (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H7685558\">",
"       'REM sleep disorder'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/1\">",
"      Ballard CG, O'Brien JT, Swann AG, et al. The natural history of psychosis and depression in dementia with Lewy bodies and Alzheimer's disease: persistence and new cases over 1 year of follow-up. J Clin Psychiatry 2001; 62:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/2\">",
"      Ballard C, O'Brien J, Swann A, et al. One year follow-up of parkinsonism in dementia with Lewy bodies. Dement Geriatr Cogn Disord 2000; 11:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/3\">",
"      Hamilton JM, Salmon DP, Galasko D, et al. Visuospatial deficits predict rate of cognitive decline in autopsy-verified dementia with Lewy bodies. Neuropsychology 2008; 22:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/4\">",
"      McKeith IG. Dementia with Lewy bodies. Br J Psychiatry 2002; 180:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/5\">",
"      Ballard C, O'Brien J, Morris CM, et al. The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease. Int J Geriatr Psychiatry 2001; 16:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/6\">",
"      Walker Z, Allen RL, Shergill S, et al. Three years survival in patients with a clinical diagnosis of dementia with Lewy bodies. Int J Geriatr Psychiatry 2000; 15:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/7\">",
"      O'Brien JT, Paling S, Barber R, et al. Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia. Neurology 2001; 56:1386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/8\">",
"      Stavitsky K, Brickman AM, Scarmeas N, et al. The progression of cognition, psychiatric symptoms, and functional abilities in dementia with Lewy bodies and Alzheimer disease. Arch Neurol 2006; 63:1450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/9\">",
"      Olichney JM, Galasko D, Salmon DP, et al. Cognitive decline is faster in Lewy body variant than in Alzheimer's disease. Neurology 1998; 51:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/10\">",
"      Del Ser T, Hachinski V, Merskey H, Munoz DG. Clinical and pathologic features of two groups of patients with dementia with Lewy bodies: effect of coexisting Alzheimer-type lesion load. Alzheimer Dis Assoc Disord 2001; 15:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/11\">",
"      Williams MM, Xiong C, Morris JC, Galvin JE. Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease. Neurology 2006; 67:1935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/12\">",
"      Lopez OL, Wisniewski S, Hamilton RL, et al. Predictors of progression in patients with AD and Lewy bodies. Neurology 2000; 54:1774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/13\">",
"      Rolinski M, Fox C, Maidment I, McShane R. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease. Cochrane Database Syst Rev 2012; 3:CD006504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/14\">",
"      Simard M, van Reekum R. The acetylcholinesterase inhibitors for treatment of cognitive and behavioral symptoms in dementia with Lewy bodies. J Neuropsychiatry Clin Neurosci 2004; 16:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/15\">",
"      Lanct&ocirc;t KL, Herrmann N. Donepezil for behavioural disorders associated with Lewy bodies: a case series. Int J Geriatr Psychiatry 2000; 15:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/16\">",
"      Beversdorf DQ, Warner JL, Davis RA, et al. Donepezil in the treatment of dementia with lewy bodies. Am J Geriatr Psychiatry 2004; 12:542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/17\">",
"      Edwards K, Royall D, Hershey L, et al. Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study. Dement Geriatr Cogn Disord 2007; 23:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/18\">",
"      McKeith IG, Grace JB, Walker Z, et al. Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial. Int J Geriatr Psychiatry 2000; 15:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/19\">",
"      McKeith I, Del Ser T, Spano P, et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet 2000; 356:2031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/20\">",
"      Mori E, Ikeda M, Kosaka K, Donepezil-DLB Study Investigators. Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled trial. Ann Neurol 2012; 72:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/21\">",
"      Samuel W, Caligiuri M, Galasko D, et al. Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study. Int J Geriatr Psychiatry 2000; 15:794.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/22\">",
"      Onofrj M, Thomas A. Severe worsening of parkinsonism in Lewy body dementia due to donepezil. Neurology 2003; 61:1452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/23\">",
"      Morita S, Miwa H, Kondo T. [A patient with probable dementia with Lewy bodies, who showed catatonia induced by donepezil: a case report]. No To Shinkei 2004; 56:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/24\">",
"      Ballard CG, Chalmers KA, Todd C, et al. Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies. Neurology 2007; 68:1726.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/25\">",
"      Aarsland D, Ballard C, Walker Z, et al. Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial. Lancet Neurol 2009; 8:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/26\">",
"      Emre M, Tsolaki M, Bonuccelli U, et al. Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2010; 9:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/27\">",
"      Ridha BH, Josephs KA, Rossor MN. Delusions and hallucinations in dementia with Lewy bodies: worsening with memantine. Neurology 2005; 65:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/28\">",
"      Sabbagh MN, Hake AM, Ahmed S, Farlow MR. The use of memantine in dementia with Lewy bodies. J Alzheimers Dis 2005; 7:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/29\">",
"      Olson EJ, Boeve BF, Silber MH. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain 2000; 123 ( Pt 2):331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/30\">",
"      Boeve BF, Silber MH, Ferman TJ. Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med 2003; 4:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/31\">",
"      Gagnon JF, Postuma RB, Montplaisir J. Update on the pharmacology of REM sleep behavior disorder. Neurology 2006; 67:742.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/32\">",
"      Kurlan R, Cummings J, Raman R, et al. Quetiapine for agitation or psychosis in patients with dementia and parkinsonism. Neurology 2007; 68:1356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/33\">",
"      Walker Z, Grace J, Overshot R, et al. Olanzapine in dementia with Lewy bodies: a clinical study. Int J Geriatr Psychiatry 1999; 14:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/34\">",
"      Cummings JL, Street J, Masterman D, Clark WS. Efficacy of olanzapine in the treatment of psychosis in dementia with lewy bodies. Dement Geriatr Cogn Disord 2002; 13:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/35\">",
"      Leopold NA. Risperidone treatment of drug-related psychosis in patients with parkinsonism. Mov Disord 2000; 15:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/36\">",
"      Tariot PN, Ismail MS. Use of quetiapine in elderly patients. J Clin Psychiatry 2002; 63 Suppl 13:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/37\">",
"      Rasmussen KG Jr, Russell JC, Kung S, et al. Electroconvulsive therapy for patients with major depression and probable Lewy body dementia. J ECT 2003; 19:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/38\">",
"      Molloy S, McKeith IG, O'Brien JT, Burn DJ. The role of levodopa in the management of dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2005; 76:1200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/39\">",
"      Bonelli SB, Ransmayr G, Steffelbauer M, et al. L-dopa responsiveness in dementia with Lewy bodies, Parkinson disease with and without dementia. Neurology 2004; 63:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/40\">",
"      Lucetti C, Logi C, Del Dotto P, et al. Levodopa response in dementia with lewy bodies: a 1-year follow-up study. Parkinsonism Relat Disord 2010; 16:522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/41\">",
"      Kato K, Wada T, Kawakatsu S, Otani K. Improvement of both psychotic symptoms and Parkinsonism in a case of dementia with Lewy bodies by the combination therapy of risperidone and L-DOPA. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/42\">",
"      Yamauchi K, Takehisa M, Tsuno M, et al. Levodopa improved rapid eye movement sleep behavior disorder with diffuse Lewy body disease. Gen Hosp Psychiatry 2003; 25:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/43\">",
"      Fernandez HH, Wu CK, Ott BR. Pharmacotherapy of dementia with Lewy bodies. Expert Opin Pharmacother 2003; 4:2027.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/44\">",
"      Drugs to treat autonomic dysfunction in Parkinson's disease. Mov Disord 2002; 17 Suppl 4:S103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21031/abstract/45\">",
"      Thaisetthawatkul P, Boeve BF, Benarroch EE, et al. Autonomic dysfunction in dementia with Lewy bodies. Neurology 2004; 62:1804.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5092 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-983B24DA49-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_34_21031=[""].join("\n");
var outline_f20_34_21031=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H9\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      General strategies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7685079\">",
"      Cognition and neuropsychiatric disturbances",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Cholinesterase inhibitors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7685485\">",
"      - Memantine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7685558\">",
"      - REM sleep disorder",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Neuroleptics",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7685205\">",
"      - Other psychotropic medications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Antiparkinson medications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7685065\">",
"      Orthostatic hypotension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1913?source=related_link\">",
"      Cholinesterase inhibitors in the treatment of dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1914?source=related_link\">",
"      Clinical features and diagnosis of dementia with Lewy bodies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/41/34455?source=related_link\">",
"      Epidemiology, pathology, and pathogenesis of dementia with Lewy bodies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/25/408?source=related_link\">",
"      Frontotemporal dementia: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/11/4277?source=related_link\">",
"      Nonpharmacologic management of Parkinson disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/36/15946?source=related_link\">",
"      Parkinson disease dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?14/37/14934?source=related_link\">",
"      Patient information: Dementia (including Alzheimer disease) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/3/18482?source=related_link\">",
"      Patient information: Dementia with Lewy bodies (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/63/32762?source=related_link\">",
"      Pharmacologic treatment of Parkinson disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/10/15530?source=related_link\">",
"      Second-generation antipsychotic medications: Pharmacology, administration, and comparative side effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/55/10104?source=related_link\">",
"      Treatment and prevention of vascular dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27402?source=related_link\">",
"      Treatment of behavioral symptoms related to dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/4/33865?source=related_link\">",
"      Treatment of dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/2/5161?source=related_link\">",
"      Treatment of orthostatic and postprandial hypotension",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f20_34_21032="Basic case 15 with answer";
var content_f20_34_21032=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F77122&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F77122&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Late evolution of anterior MI",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 277px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Later stage in the evolution of an acute anterior ST-elevation/Q wave myocardial infarction. There is a QS pattern in leads V1 to V3 and T wave inversion in leads V2 to V4. The ST segment elevations in these leads have almost disappeared.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ary Goldberger, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_34_21032=[""].join("\n");
var outline_f20_34_21032=null;
var title_f20_34_21033="Ovarian cysts and neoplasms in infants, children, and adolescents";
var content_f20_34_21033=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Ovarian cysts and neoplasms in infants, children, and adolescents",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/34/21033/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/34/21033/contributors\">",
"     Marc R Laufer, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/34/21033/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/34/21033/contributors\">",
"     John L Kirkland, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/34/21033/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/34/21033/contributors\">",
"     Amy B Middleman, MD, MPH, MS Ed",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/34/21033/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/34/21033/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?20/34/21033/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 14, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ovarian masses occur in children and young girls and can be discovered due to symptoms, on physical examination,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    through imaging studies. The probable histology varies according to the age of the patient. Masses in the pelvis, although usually of gynecologic origin, can also arise from the urinary tract, bowel, or other pelvic structures [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ovarian masses may represent physiologic cysts, benign neoplasms, or malignant neoplasms. They may be associated with pain or present as an asymptomatic mass. Although relatively rare, they are the most common genital neoplasms occurring in childhood [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/2\">",
"     2",
"    </a>",
"    ]. Historically, all ovarian masses discovered in infants, children, and adolescents were removed surgically. However, the identification of tumor markers and advances in radiologic imaging allow a more conservative approach to the management of these neoplasms, with ovarian preservation as the standard except in cases of cancer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The World Health Organization classifies ovarian neoplasms based upon histologic cell type and benign versus malignant state (",
"    <a class=\"graphic graphic_table graphicRef77703 \" href=\"UTD.htm?1/41/1693\">",
"     table 1",
"    </a>",
"    ). The majority of ovarian tumors in girls and adolescents are of germ cell origin. By comparison, epithelial tumors account for the largest proportion of ovarian neoplasms in adults. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/37/5721?source=see_link\">",
"     \"Ovarian germ cell neoplasms: Pathology, clinical manifestations, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/6/31849?source=see_link\">",
"     \"Epithelial carcinoma of the ovary, fallopian tube, and peritoneum: Clinical features and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most childhood ovarian masses are benign. However, it is important for the clinician to establish an early diagnosis to reduce the risk of ovarian torsion with possible loss of adnexa and to improve the prognosis for those lesions that are malignant. (See",
"    <a class=\"local\" href=\"#H28\">",
"     'Ovarian cancer'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     OVARIAN CYSTS IN THE FETUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Follicular ovarian cysts in fetuses and neonates are common and increase in frequency with advancing gestational age and some maternal complications, such as diabetes mellitus, preeclampsia, and rhesus isoimmunization [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. In one autopsy series of 332 ovaries from stillbirths and neonatal deaths, one or more follicular cysts lined by granulosa epithelium and having a diameter greater than 1 mm were detected in 113 infants [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/3\">",
"     3",
"    </a>",
"    ]. Among live births, the best estimate of the incidence of clinically significant ovarian cysts is 1 in 2500 [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnosis is based upon sonographically determined presence of four criteria: female sex, nonmidline regular cystic structure, normal-appearing urinary tract, and normal-appearing gastrointestinal tract [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/4\">",
"     4",
"    </a>",
"    ]. Size and appearance are used to characterize cysts as probably physiologic or probably pathologic. Simple cysts less than 2 cm in diameter are considered physiologic. Larger and complex cysts are more likely to be nonphysiologic. Associated anomalies are rare since the cysts usually result from hormonal stimulation [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/4\">",
"     4",
"    </a>",
"    ]. In one report, congenital hypothyroidism was associated with fetal ovarian cysts [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Follicular cysts are commonly detected incidentally on antenatal ultrasound examination (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef74210 \" href=\"UTD.htm?21/38/22113\">",
"     image 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/7\">",
"     7",
"    </a>",
"    ]. The etiology is unclear, but they most likely arise from ovarian stimulation by maternal and fetal gonadotropin [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/4\">",
"     4",
"    </a>",
"    ]. The majority of fetal ovarian cysts are unilateral, although both ovaries may be involved.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of a fetal cystic intraabdominal mass includes genitourinary tract disorders (eg, reproductive tract anomalies, urinary tract obstruction, urachal cyst), gastrointestinal tract disorders (eg, mesenteric or omental cyst, volvulus, colonic atresia, intestinal duplication), or miscellaneous disorders (eg, choledochal, splenic, or pancreatic cyst, lymphangioma).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Management and outcome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spontaneous regression of both simple and complex cysts often occurs either antenatally or postpartum by six months of age, therefore management is usually expectant. In one review of 66 published cases of simple cysts, 50 percent resolved by one month of age, 75 percent by two months, and 90 percent by three months [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/5\">",
"     5",
"    </a>",
"    ]. The rate of malignancy is so low that it need not be considered in making therapeutic decisions.",
"   </p>",
"   <p>",
"    Ultrasound examination should be performed every three to four weeks antenatally. After birth, neonatal management is as described below. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Ovarian cysts in neonates'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Complications that can occur include intracystic hemorrhage, rupture with possible intraabdominal hemorrhage, gastrointestinal or urinary tract obstruction, ovarian torsion and necrosis, incarceration in an inguinal hernia, difficulty with delivery due to fetal abdominal dystocia, and respiratory distress at birth from a mass effect on the diaphragm (",
"    <a class=\"graphic graphic_table graphicRef59977 \" href=\"UTD.htm?7/5/7259\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. If in-utero torsion occurs, the ovary may undergo necrosis and develop into a calcified mass, a sessile mass, or disappear entirely. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/8/23690?source=see_link\">",
"     \"Ovarian and fallopian tube torsion\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a long-term follow-up study of 21 girls with prenatal ovarian cysts, sonographic follow-up was obtained in 14. There was inability to appreciate the ovary in 8 of 11 ovaries in which the cysts appeared complex on the first postnatal scan (two were treated with postnatal salpingo-oophorectomy; one was treated with postnatal aspiration; the remainder were observed) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/10\">",
"     10",
"    </a>",
"    ]. These data suggest that prenatally detected ovarian cysts should be closely monitored, particularly if the cyst appears complex on postnatal sonography, due to the increased risk of torsion and subsequent ovarian loss",
"   </p>",
"   <p>",
"    Antenatal aspiration of large cysts (greater than 4 to 6 cm) under ultrasound guidance has been advocated to reduce the risk of complications [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/11-14\">",
"     11-14",
"    </a>",
"    ]; however, the role of this technique is questionable because of possible misdiagnosis and potential complications from the aspiration technique itself [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/15\">",
"     15",
"    </a>",
"    ]. In particular, small anechoic cysts are likely to resolve spontaneously and should be left alone [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/12\">",
"     12",
"    </a>",
"    ]. On the other hand, a large cyst that undergoes torsion may lead to loss of the ovary and impair future fertility [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/4\">",
"     4",
"    </a>",
"    ]. Advantages of aspiration include elimination of the cyst with reduction of the risk of cyst-related complications and need for neonatal surgery. Disadvantages are risk of spillage and absence of data on the true risks and benefits of this procedure. Complex cysts cannot be aspirated.",
"   </p>",
"   <p>",
"    Most fetuses can be delivered vaginally with cesarean delivery reserved for the usual obstetric indications [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/4\">",
"     4",
"    </a>",
"    ]. Cesarean birth may be the preferred route of delivery of fetuses with very large cysts to prevent rupture",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    dystocia. Cyst aspiration antepartum is an alternative approach.",
"   </p>",
"   <p>",
"    There is no increased risk of recurrence in subsequent pregnancies [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     OVARIAN CYSTS IN NEONATES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Clinical features and diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A pelvic mass in a newborn is most likely a physiologic cyst on the fetal ovary resulting from maternal hormonal stimulation in-utero. The differential diagnosis is the same as that for fetuses [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Differential diagnosis'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Neonatal cysts may have been initially detected on antenatal sonographic examination or may be identified as an asymptomatic abdominal mass because of displacement upward and out of the narrow neonatal pelvis. The ovary containing the cyst is generally freely mobile.",
"   </p>",
"   <p>",
"    Ultrasound examination may show a simple (clear, fluid-filled) or complex (fluid, debris, septa, solid components, echogenic wall) sonographic pattern. A complex sonographic appearance makes a precise diagnosis more difficult. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/40/34440?source=see_link\">",
"     \"Sonographic differentiation of benign versus malignant adnexal masses\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Ovarian torsion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Torsion can occur with a cyst of any size, particularly when long pedicles are present [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/17\">",
"     17",
"    </a>",
"    ]. Parents or other caregivers should be made aware of the signs and symptoms of torsion (lower abdominal pain of sudden onset, nausea, vomiting, low-grade fever) so they can seek emergent care without delay. An ultrasound evaluation showing a size discrepancy in the ovarian volumes with classic peripheralization of follicles is helpful in determining the diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An attempt should always be made to salvage the torsed ovary by untwisting the vascular pedicle. A bivalve technique (ie, opening of the ovarian cortex with a linear incision) can be used to try to salvage a dark-appearing torsed ovary; this technique decreases the intraovarian pressure caused by venous occlusion and permits arterial flow into the ovary [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/19\">",
"     19",
"    </a>",
"    ]. However, in rare instances, oophorectomy is necessary because of severe necrosis, or nonviable appearance [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/20\">",
"     20",
"    </a>",
"    ]. Normal ovaries may also undergo torsion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/8/23690?source=see_link\">",
"     \"Ovarian and fallopian tube torsion\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spontaneous regression usually occurs by four to six months of age. The generally agreed-upon management of neonatal cysts consists of:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Serial ultrasound examinations at birth and every four to six weeks thereafter until the cyst resolves, enlarges, has persisted for four to six months, or becomes symptomatic. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Serial ultrasound'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Aspiration of simple cysts &ge;4 to 5 cm [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/4\">",
"       4",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Aspiration'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Surgical intervention for complex cysts, cysts that are increasing in size, symptomatic cysts, and cysts persisting for more than four to six months [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/6,21,22\">",
"       6,21,22",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Surgical excision'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Serial ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serial ultrasound examinations should be performed at birth and every four to six weeks thereafter to confirm regression. The most serious concerns are malignancy and the possibility of torsion with subsequent ovarian loss, either of which is likely if the cyst does not resolve. Failure to regress also increases the suspicion that the cyst represents nonovarian pathology.",
"   </p>",
"   <p>",
"    Serial ultrasound examinations should continue until the cyst resolves, enlarges, has persisted for four to six months, or becomes symptomatic. Surgical intervention may be warranted for cysts that enlarge, persist for four to six months, or become symptomatic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Aspiration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postpartum cyst aspiration has been advocated to reduce the likelihood of torsion. In contrast to antenatal cyst aspiration, the value and safety of neonatal cyst aspiration has been clearly established because the diagnosis is more certain and the risk of complications is low [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/5,23\">",
"     5,23",
"    </a>",
"    ]. Aspiration may be indicated for simple neonatal ovarian cysts that are &ge;4 to 5 cm [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/4\">",
"     4",
"    </a>",
"    ]. However, a period of observation is always prudent, as the cyst may regress spontaneously, and thus, there is no need for aspiration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Surgical excision",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical excision is generally indicated for intervention for cysts that are complex, symptomatic, increasing in size, or persisting for more than four to six months [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/6,21,22\">",
"     6,21,22",
"    </a>",
"    ]. Laparoscopic surgery is feasible and safe in neonates with ovarian cysts.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Outcome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spontaneous regression usually occurs by four to six months of age. Approximately 50 percent resolve in the first three months of life, but 30 to 40 percent undergo torsion or another complication (",
"    <a class=\"graphic graphic_table graphicRef59977 \" href=\"UTD.htm?7/5/7259\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     OVARIAN CYSTS IN INFANTS AND PREPUBERTAL CHILDREN",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Etiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Physiologic cysts are uncommon between the neonatal period and puberty because gonadotropin stimulation of the ovary decreases in infancy and early childhood and then increases as puberty is approached. Nevertheless, most simple ovarian cysts in children are physiologic and result from enlargement of a cystic follicle.",
"   </p>",
"   <p>",
"    Some ovarian cysts are hormonally active and result in precocious pseudopuberty (eg, McCune-Albright syndrome) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/25\">",
"     25",
"    </a>",
"    ]. In girls with hormonally active cysts, the ovarian enlargement may be mistaken for an ovarian tumor, leading to unnecessary oophorectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/26\">",
"     26",
"    </a>",
"    ]. Girls presenting with premature vaginal bleeding and ovarian enlargement should be evaluated for features of McCune-Albright syndrome (",
"    <a class=\"graphic graphic_picture graphicRef80844 \" href=\"UTD.htm?41/51/42815\">",
"     picture 1",
"    </a>",
"    ) to avoid this potential mistake. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/5/19546?source=see_link&amp;anchor=H9#H9\">",
"     \"Definition, etiology, and evaluation of precocious puberty\", section on 'Causes of gonadotropin independent precocious puberty (GIPP)'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other ovarian cysts occur in response to gonadotropin stimulation in patients with idiopathic central precocious puberty; these should resolve after administration of gonadotropin-releasing hormone analog therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/27\">",
"     27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/49/4889?source=see_link&amp;anchor=H23809056#H23809056\">",
"     \"Treatment of precocious puberty\", section on 'McCune-Albright syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;An ovarian cyst in a young child is often discovered by a parent or clinician as an asymptomatic abdominal mass or because of increasing abdominal girth. In a retrospective review of 1818 ultrasonographic studies in prepubertal girls, ovarian cysts were identified in 99 (5 percent); in 62 percent of cases, the cyst was an incidental finding [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The embryological ovary migrates from the level of the 10th thoracic vertebrae and descends to the true pelvis by puberty. Thus, in early life, the ovary is an abdominal organ and more susceptible to torsion.",
"   </p>",
"   <p>",
"    Chronic abdominal aching pain, either periumbilical or localized to a lower quadrant, may be present. Acute severe pain simulating appendicitis or peritonitis may result from torsion, perforation, infarction, or hemorrhage (into or from the ovarian mass). Alternatively, the child may complain of intermittent pain, presumably because of partial or intermittent torsion, which may resolve without therapy or act as a warning sign of impending torsion requiring emergency surgery. Torsion also causes nausea, vomiting, pallor, and leukocytosis (with left shift), often followed by less severe localized pain. Nonspecific symptoms suggestive of a large tumor include a sense of abdominal fullness or bloating and urinary frequency or retention. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/8/23690?source=see_link\">",
"     \"Ovarian and fallopian tube torsion\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasonography is the primary assessment tool. If torsion is suspected because of pain, the addition of Doppler ultrasound may be helpful. However, Doppler is not always conclusive since Doppler flow can be appreciated in a torsed ovary without complete cessation of blood flow, and, alternatively, Doppler flow can be absent in normal ovaries. Computed tomography and magnetic resonance imaging have also been used in an attempt to clarify equivocal findings; the value of these studies has not been established.",
"   </p>",
"   <p>",
"    Children with recurrent, large, or multicystic ovarian masses and signs of early sexual development should be evaluated for precocious puberty (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/5/19546?source=see_link\">",
"     \"Definition, etiology, and evaluation of precocious puberty\"",
"    </a>",
"    ). In the absence of precocity, the possibility of a periovarian or mesothelial cyst should be considered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Management and outcome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of an ovarian cyst in the prepubertal age group depends upon the appearance of the cyst on ultrasonography, clinical manifestations, and the presence of significant symptoms.",
"   </p>",
"   <p>",
"    An ovarian mass that is purely cystic or has few internal echoes suggestive of hemorrhage and no complex features (septation or calcification) is almost certainly benign and can be managed by observation. A follow-up ultrasound examination in four to eight weeks should be performed. If the cyst has not resolved and the ultrasonic characteristics are still reassuring, then continued observation is appropriate as long as the girl remains asymptomatic.",
"   </p>",
"   <p>",
"    In a retrospective review of simple and complex cysts (greater than 5 cm in diameter) in 92 girls (average age 14.9 years), 23 were treated surgically either because of the initial ultrasonic appearance or persistence; 10 were found to have neoplasms (six teratomas, two cystadenomas, one granulosa cell tumor, one Sertoli-Leydig cell tumor). Among the 51 patients who were managed expectantly, eight were prepubertal; 90 percent of the cysts spontaneously resolved within approximately two weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/29\">",
"     29",
"    </a>",
"    ]. Another series of 64 children with simple cysts less than 5.5 cm in diameter found that all resolved spontaneously over time [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If acute rupture with hemorrhage occurs, it is important to determine whether the bleeding appears to be self-limited or associated with hemodynamic instability. In the latter case, the child should be stabilized and then taken to surgery, which can usually be performed laparoscopically [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. A hemoperitoneum is not a contraindication to laparoscopy. Free blood and clots are aspirated and hemostasis assured by fulguration of the areas of bleeding. Laparotomy is indicated if the surgeon is not experienced in laparoscopic procedures on children or if the patient is hypotensive and cannot be promptly stabilized.",
"   </p>",
"   <p>",
"    In contrast, surgery is always indicated at the time of diagnosis of ovarian torsion because a torsed ovary can usually be salvaged. Untwisting can be accomplished laparoscopically [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/31,33-35\">",
"     31,33-35",
"    </a>",
"    ]. It is unclear whether oophoropexy of the contralateral ovary should be performed to prevent torsion of the normal ovary. Oophoropexy can also be safely performed laparoscopically [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/36\">",
"     36",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/8/23690?source=see_link\">",
"     \"Ovarian and fallopian tube torsion\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/6/12393?source=see_link\">",
"     \"Oophorectomy and ovarian cystectomy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Ovarian masses associated with torsion are usually benign. As an example, a series describing 102 girls aged 2 days to 20 years who underwent 106 consecutive separate ovarian operations found 42 percent",
"    <span class=\"nowrap\">",
"     (25/59)",
"    </span>",
"    of those who presented with acute abdominal pain had ovarian torsion; the ovarian mass was malignant in only one of these girls [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/37\">",
"     37",
"    </a>",
"    ]. In contrast, 26 percent",
"    <span class=\"nowrap\">",
"     (6/23)",
"    </span>",
"    of those presenting with asymptomatic abdominal masses had malignancies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     OVARIAN CYSTS IN ADOLESCENTS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Young women between menarche and 18 years of age constitute an age group in which the development of both simple and complex cysts is quite common. Adolescent ovaries may contain multiple follicles in different stages of development. Most simple cysts result from failure of the maturing follicle to ovulate and involute.",
"   </p>",
"   <p>",
"    Cysts in the postmenarcheal adolescent may be asymptomatic (and found incidentally), but can cause menstrual irregularities, pelvic pain, or, if large, urinary frequency, constipation, or pelvic heaviness. Rupture leads to intraabdominal pain and bleeding, which can be minor or severe. Torsion also causes acute pain, as well as nausea, vomiting, pallor, and leukocytosis (with left shift), often followed by less severe localized pain.",
"   </p>",
"   <p>",
"    It is unclear why some nonruptured functional cysts cause symptoms and others do not.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of ovarian cysts in the adolescent patient is complex because of the functioning ovary, the onset of sexual activity, and the possibility of pregnancy. Although the majority of cystic masses in this age group are physiologic cysts, other possibilities must be considered and include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Obstructive genital lesions (eg, imperforate hymen, noncommunicating uterine horn); congenital obstructive lesions often occur in association with absent menstrual cycles and cyclic lower abdominal pain. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/11/12473?source=see_link\">",
"       \"Diagnosis and management of congenital anomalies of the vagina\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Ovarian tumors (eg, benign cystic teratomas) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/57/19352?source=see_link\">",
"       \"Differential diagnosis of the adnexal mass\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Tubal conditions (eg, paratubal cyst, ectopic pregnancy, salpingitis) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/9/1178?source=see_link\">",
"       \"Clinical manifestations, diagnosis, and management of ectopic pregnancy\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/0/1032?source=see_link\">",
"       \"Clinical features and diagnosis of pelvic inflammatory disease\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Uterine masses (eg, cornual ectopic gestation, leiomyoma, pregnancy) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/17/6426?source=see_link\">",
"       \"Epidemiology, clinical manifestations, diagnosis, and natural history of uterine leiomyomas (fibroids)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Gastrointestinal conditions (eg, appendiceal abscess) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/3/32826?source=see_link\">",
"       \"Acute appendicitis in children: Clinical manifestations and diagnosis\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evaluation should include a detailed menstrual and sexual history, including assessment of dysmenorrhea and contraceptive use, and physical examination.",
"   </p>",
"   <p>",
"    The presence of calcification on ultrasound examination or an abdominal radiograph suggests a teratoma. Color Doppler velocimetry of adnexal masses is used to detect low peripheral resistance, which can result from neovascularization related to malignancy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/40/34440?source=see_link\">",
"     \"Sonographic differentiation of benign versus malignant adnexal masses\"",
"    </a>",
"    .) A pregnancy test and complete blood count are obtained, as indicated, based upon clinical assessment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Management and outcome",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Follicular cysts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most follicular cysts found on routine examination in adolescents resolve spontaneously in one to two months. Asymptomatic simple cysts &lt;6 cm on ultrasound examination can be observed with or without administration of oral contraceptive pills. Some clinicians administer oral contraceptives to suppress the ovarian-hypothalamic axis so new cysts will not form and possibly confuse the clinician as to whether the first cyst resolved and a new one developed or the original cyst persisted. However, modern low-dose oral contraceptive pills appear to have minimal efficacy in preventing development of functional cysts [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/38\">",
"     38",
"    </a>",
"    ]. The patient should be evaluated monthly by bimanual or ultrasound examination.",
"   </p>",
"   <p>",
"    If a fluid-filled cyst increases in size, is greater than 6 cm, or causes symptoms, then a laparoscopic cystectomy may be warranted. It is possible that cysts larger than 6 cm will regress spontaneously, and thus, observation is an alternative. If a cystectomy is performed, the cyst wall should be sent for pathologic examination. Ovarian cystectomy is preferred to cyst aspiration due to the high rate of recurrence after aspiration [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/39\">",
"     39",
"    </a>",
"    ]. Asymptomatic simple cysts of 6 to 10 cm may also spontaneously resolve and can be safely observed. If the cyst recurs or operative intervention is needed, the procedure should be conservative and preserve as much ovarian tissue as possible. Patients incidentally found to have small follicular cysts at the time of surgery should not undergo cyst aspiration or cystectomy, as these cysts will resolve spontaneously; ovarian and peritubal adhesions may form from ovarian surgery and result in infertility",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pelvic pain [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Corpus luteum cysts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Corpus luteum cysts are also common. They result from the normal formation of a corpus luteum after ovulation and can reach 5 to 12 cm in diameter. The ultrasound appearance of these cysts is characterized by increased internal echoes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/40/34440?source=see_link\">",
"     \"Sonographic differentiation of benign versus malignant adnexal masses\"",
"    </a>",
"    .) Bleeding into the cyst or rupture with intraperitoneal hemorrhage may occur.",
"   </p>",
"   <p>",
"    In the absence of pain or intraperitoneal bleeding, observation for a time period between two weeks and three months and possibly therapy with oral contraceptive pills is appropriate. The oral contraceptive pills will keep a new cyst from forming so as to decrease confusion at the follow-up ultrasound, but do not help the current cyst regress. Most corpus luteal cysts will involute during the two-week to three-month observation period. There is no upper size limit for observation; even large corpus luteal cysts can be observed without the need for surgical intervention. Corpus luteum cysts are at increased risk of torsion due to increased ovarian size and weight. Even with hemorrhage or severe pain, observation is the first-line therapy. The cyst will usually resolve spontaneously, and the free intraperitoneal blood will be reabsorbed. Surgery is rarely needed.",
"   </p>",
"   <p>",
"    <span class=\"nowrap\">",
"     Persistent/noninvoluting",
"    </span>",
"    ovarian cysts should be managed surgically with removal of the cyst and cyst wall and conservation of the ovary. Even large (greater than 10 cm) cysts can be managed with an ovarian cystectomy and conservation of the stretched-out normal ovarian cortex with preservation of normal ovarian tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     OVARIAN CANCER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ovarian neoplasms account for approximately 1 percent of all tumors in children and adolescents. Most ovarian neoplasms are physiologic or benign; fewer than 5 percent of ovarian malignancies occur in this age group. However, ovarian enlargement, whether cystic or solid, in these patients must be evaluated to exclude malignancy because approximately 10 to 20 percent of all ovarian masses occurring during childhood and adolescence are malignant [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/37,42,43\">",
"     37,42,43",
"    </a>",
"    ]. Approximately 35 to 45 percent of ovarian cancers in children are germ cell tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/44,45\">",
"     44,45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ovarian cancer is the most common gynecologic malignancy in women &le;25 years of age, and germ cell is the most common histology [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/44\">",
"     44",
"    </a>",
"    ]. Germ cell tumors make up one-half to two-thirds of ovarian neoplasms in girls up to 18 years of age compared with 20 percent of ovarian tumors in adult women. In girls younger than nine years of age, approximately 80 percent of ovarian neoplasms are malignant. Epithelial neoplasms are rare in the prepubertal age group. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/37/5721?source=see_link\">",
"     \"Ovarian germ cell neoplasms: Pathology, clinical manifestations, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/52/17224?source=see_link\">",
"     \"Epithelial ovarian cancer: Pathology\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with an ovarian tumor may present with abdominal pain or complaints of increasing abdominal girth, nausea, and vomiting; or they may be asymptomatic, with the mass being found on routine examination [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/46\">",
"     46",
"    </a>",
"    ]. The wide variety of symptoms caused by ovarian tumors suggests that abdominal palpation and rectal examination in the dorsal supine position are important in any girl with nonspecific abdominal or pelvic complaints. Nonspecific symptoms may be more common with epithelial than germ cell ovarian tumors. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/37/5721?source=see_link\">",
"     \"Ovarian germ cell neoplasms: Pathology, clinical manifestations, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/6/31849?source=see_link&amp;anchor=H27#H27\">",
"     \"Epithelial carcinoma of the ovary, fallopian tube, and peritoneum: Clinical features and diagnosis\", section on 'Clinical presentation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A large, thin-walled cyst may be confused with ascites. Exquisite tenderness suggests torsion or hemorrhage, but may also occur with other nongynecologic conditions, such as appendicitis. The size of the tumor is not indicative of its malignant potential.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sonography is used routinely to determine the overall size of the mass and identify whether it is simple, complex, solid, bilateral, or associated with free fluid. The pattern of blood supply can be evaluated by Doppler flow characteristics. This information, along with the age of the patient, clinical manifestations, and presence of tumor markers, is vital in forming a differential diagnosis.",
"   </p>",
"   <p>",
"    A solid ovarian mass in childhood is always considered malignant until proven otherwise by histological examination. The differential diagnosis of solid tumors includes dysgerminoma, neuroblastoma, Wilms' tumor, rhabdomyosarcoma, lymphoma, leukemia, and other nongenital tumors located in the pelvis. Additional information can be obtained through use of computed tomography or magnetic resonance imaging.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Tumor markers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some ovarian neoplasms secrete protein tumor markers that can be assayed from peripheral blood samples. Tumor markers can be helpful in making a diagnosis and following the clinical response to treatment. Some examples of ovarian tumor markers include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Alpha-fetoprotein (AFP) is an oncofetal antigen that is a glycoprotein. It is produced by endodermal sinus tumors, mixed germ cell tumors, and immature teratomas.",
"     </li>",
"     <li>",
"      Lactate dehydrogenase (LDH) is elevated with dysgerminomas",
"     </li>",
"     <li>",
"      CA-125 is a marker for epithelial ovarian cancer that is highly sensitive, but not very specific, since it is elevated with many intraperitoneal processes (eg, endometriosis, pelvic inflammatory disease, pregnancy, Crohn's disease)",
"     </li>",
"     <li>",
"      Human chorionic gonadotropin (hCG) is produced by trophoblastic cells and thus will be elevated with pregnancy, hydatidiform moles, placental site tumors, nongestational choriocarcinoma, and embryonal ovarian carcinomas",
"     </li>",
"     <li>",
"      Carcinoembryonic antigen (CEA) can be produced by epithelial or germ cell tumors",
"     </li>",
"     <li>",
"      Inhibin and mullerian inhibiting substance (MIS) concentrations are elevated in children with granulosa-theca cell tumors",
"     </li>",
"     <li>",
"      Thrombocytosis has been associated with ovarian malignancies in girls and adolescents [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/47\">",
"       47",
"      </a>",
"      ]. Because it is readily available, the platelet count is useful in the emergency evaluation of a torsed ovary with suspicion for malignancy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Staging",
"    </span>",
"    &nbsp;&mdash;&nbsp;The staging of malignant ovarian tumors has been defined by the International Federation of Gynecologists and Obstetricians (",
"    <a class=\"graphic graphic_table graphicRef51205 \" href=\"UTD.htm?14/43/15038\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical intervention is directed toward preservation of reproductive and sexual function. Unless a malignancy is diagnosed definitively on frozen section at the time of the procedure, conservative surgery should be undertaken with excision of the lesion and ovarian reconstruction. Even large ovarian cysts can be removed with preservation of the normal ovarian cortex [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21033/abstract/41\">",
"     41",
"    </a>",
"    ]. If the tumor markers are abnormal and malignancy is suspected, then a unilateral salpingo-oophorectomy and appropriate staging is performed. It is preferable to subject the patient to a second procedure after the final pathology specimens are reviewed than to perform an unnecessary ablative procedure. If malignancy is suspected or confirmed, adequate staging includes abdominal and pelvic exploration, peritoneal washings, biopsies of suspicious areas, and periaortic and pelvic lymph node sampling. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/24/33162?source=see_link\">",
"     \"Treatment of malignant germ cell tumors of the ovary\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/48/36618?source=see_link\">",
"     \"Epithelial ovarian cancer: Initial surgical management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Follicular ovarian cysts in fetuses are common. The ultrasonographic size and appearance are used to classify the cysts as probably physiologic or probably pathologic. Simple cysts less than 2 cm in diameter are considered physiologic. Spontaneous regression of both simple and complex cysts often occurs either antenatally or by six months of age. Management is usually expectant. Potential complications (",
"      <a class=\"graphic graphic_table graphicRef59977 \" href=\"UTD.htm?7/5/7259\">",
"       table 2",
"      </a>",
"      ) are listed in the table. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Ovarian cysts in the fetus'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Physiologic neonatal ovarian cysts generally present as a freely mobile pelvic or abdominal mass. Diagnosis may be confirmed with ultrasonography. Ovarian torsion is a potential complication, and",
"      <span class=\"nowrap\">",
"       parents/caregivers",
"      </span>",
"      should be educated about possible signs and symptoms (lower abdominal pain of sudden onset, nausea, vomiting, low-grade fever). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Ovarian cysts in neonates'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Neonatal ovarian cysts usually spontaneously regress by four to six months of age. Management consists of: serial ultrasound examinations at birth and every four to six weeks until the cyst resolves, enlarges, has persisted for four to six months, or becomes symptomatic; aspiration of simple cysts &ge;4 to 5 cm; and surgical intervention for complex cysts, cysts that are increasing in size, symptomatic cysts, and cysts persisting for more than four to six months. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Overview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ovarian cysts in infants and children often present as an asymptomatic abdominal mass or with increasing abdominal girth. Associated symptoms may include abdominal pain, abdominal fullness or bloating, and urinary frequency or retention. Ultrasonography is the primary assessment tool. Children with recurrent, large, or multicystic ovarian masses and signs of early sexual development should be evaluated for precocious puberty. Management depends upon the appearance of the cyst, clinical manifestations, and symptoms. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Ovarian cysts in infants and prepubertal children'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In adolescents between menarche and 18 years of age, both simple and complex ovarian cysts are common. The cysts may be asymptomatic or cause menstrual irregularities, pelvic pain, urinary frequency, constipation, or pelvic heaviness. The differential diagnosis includes obstructive genital lesions, ovarian tumors, tubal conditions, uterine masses, and gastrointestinal conditions. Evaluation should include a detailed menstrual and sexual history, physical examination, and imaging",
"      <span class=\"nowrap\">",
"       (abdominal/pelvic",
"      </span>",
"      radiograph or ultrasonography). Pregnancy test and complete blood count also may be indicated, based upon clinical assessment. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Ovarian cysts in adolescents'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The management of follicular cysts depends upon the size and ultrasonographic appearance. (See",
"      <a class=\"local\" href=\"#H26\">",
"       'Follicular cysts'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H27\">",
"       'Corpus luteum cysts'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with ovarian tumors may present with abdominal pain, increasing abdominal girth, nausea, vomiting, or an asymptomatic abdominal mass. The size of the tumor is not indicative of its malignant potential. (See",
"      <a class=\"local\" href=\"#H28\">",
"       'Ovarian cancer'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ultrasonography is used to determine the size and whether it is simple, complex, solid, bilateral, or associated with free fluid. A solid ovarian mass in childhood is always considered malignant until proven otherwise by histological examination. (See",
"      <a class=\"local\" href=\"#H30\">",
"       'Imaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Tumor markers can be helpful in making a diagnosis and following the clinical response to treatment. (See",
"      <a class=\"local\" href=\"#H31\">",
"       'Tumor markers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Surgical intervention is directed toward preservation of reproductive function. Even in cases of large ovarian cystic masses, the ovary can be preserved. (See",
"      <a class=\"local\" href=\"#H33\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Laufer MR. Adnexal masses. In: Emans, Laufer, &amp; Goldstein&rsquo;s Pediatric and Adolescent Gynecology, 6th ed, Emans JE, Laufer MR (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2012. p.381.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/2\">",
"      Breen JL, Maxson WS. Ovarian tumors in children and adolescents. Clin Obstet Gynecol 1977; 20:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/3\">",
"      deSa DJ. Follicular ovarian cysts in stillbirths and neonates. Arch Dis Child 1975; 50:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/4\">",
"      Bryant AE, Laufer MR. Fetal ovarian cysts: incidence, diagnosis and management. J Reprod Med 2004; 49:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/5\">",
"      Sakala EP, Leon ZA, Rouse GA. Management of antenatally diagnosed fetal ovarian cysts. Obstet Gynecol Surv 1991; 46:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/6\">",
"      Jafri SZ, Bree RL, Silver TM, Ouimette M. Fetal ovarian cysts: sonographic detection and association with hypothyroidism. Radiology 1984; 150:809.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/7\">",
"      Nussbaum AR, Sanders RC, Hartman DS, et al. Neonatal ovarian cysts: sonographic-pathologic correlation. Radiology 1988; 168:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/8\">",
"      Siegel MJ. Pediatric gynecologic sonography. Radiology 1991; 179:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/9\">",
"      Armentano G, Dodero P, Natta A, et al. Fetal ovarian cysts: prenatal diagnosis and management. Report of two cases and review of literature. Clin Exp Obstet Gynecol 1998; 25:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/10\">",
"      Ben-Ami I, Kogan A, Fuchs N, et al. Long-term follow-up of children with ovarian cysts diagnosed prenatally. Prenat Diagn 2010; 30:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/11\">",
"      Perrotin F, Potin J, Haddad G, et al. Fetal ovarian cysts: a report of three cases managed by intrauterine aspiration. Ultrasound Obstet Gynecol 2000; 16:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/12\">",
"      Giorlandino C, Bilancioni E, Bagolan P, et al. Antenatal ultrasonographic diagnosis and management of fetal ovarian cysts. Int J Gynaecol Obstet 1994; 44:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/13\">",
"      Luzzatto C, Midrio P, Toffolutti T, Suma V. Neonatal ovarian cysts: management and follow-up. Pediatr Surg Int 2000; 16:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/14\">",
"      Bagolan P, Giorlandino C, Nahom A, et al. The management of fetal ovarian cysts. J Pediatr Surg 2002; 37:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/15\">",
"      Teixeira JM, Glover V, Fisk NM. Acute cerebral redistribution in response to invasive procedures in the human fetus. Am J Obstet Gynecol 1999; 181:1018.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/16\">",
"      Teele RL, Share JC. The abdominal mass in the neonate. Semin Roentgenol 1988; 23:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/17\">",
"      Croitoru DP, Aaron LE, Laberge JM, et al. Management of complex ovarian cysts presenting in the first year of life. J Pediatr Surg 1991; 26:1366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/18\">",
"      Servaes S, Zurakowski D, Laufer MR, et al. Sonographic findings of ovarian torsion in children. Pediatr Radiol 2007; 37:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/19\">",
"      Styer AK, Laufer MR. Ovarian bivalving after detorsion. Fertil Steril 2002; 77:1053.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/20\">",
"      Shalev E, Mann S, Romano S, Rahav D. Laparoscopic detorsion of adnexa in childhood: a case report. J Pediatr Surg 1991; 26:1193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/21\">",
"      Mizuno M, Kato T, Hebiguchi T, Yoshino H. Surgical indications for neonatal ovarian cysts. Tohoku J Exp Med 1998; 186:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/22\">",
"      Chiaramonte C, Piscopo A, Cataliotti F. Ovarian cysts in newborns. Pediatr Surg Int 2001; 17:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/23\">",
"      Kessler A, Nagar H, Graif M, et al. Percutaneous drainage as the treatment of choice for neonatal ovarian cysts. Pediatr Radiol 2006; 36:954.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/24\">",
"      Crombleholme TM, Craigo SD, Garmel S, D'Alton ME. Fetal ovarian cyst decompression to prevent torsion. J Pediatr Surg 1997; 32:1447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/25\">",
"      Frisch LS, Copeland KC, Boepple PA. Recurrent ovarian cysts in childhood: diagnosis of McCune-Albright syndrome by bone scan. Pediatrics 1992; 90:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/26\">",
"      Nabhan ZM, West KW, Eugster EA. Oophorectomy in McCune-Albright syndrome: a case of mistaken identity. J Pediatr Surg 2007; 42:1578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/27\">",
"      Arisaka O, Shimura N, Nakayama Y, et al. Ovarian cysts in precocious puberty. Clin Pediatr (Phila) 1989; 28:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/28\">",
"      Millar DM, Blake JM, Stringer DA, et al. Prepubertal ovarian cyst formation: 5 years' experience. Obstet Gynecol 1993; 81:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/29\">",
"      Warner BW, Kuhn JC, Barr LL. Conservative management of large ovarian cysts in children: the value of serial pelvic ultrasonography. Surgery 1992; 112:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/30\">",
"      Thind CR, Carty HM, Pilling DW. The role of ultrasound in the management of ovarian masses in children. Clin Radiol 1989; 40:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/31\">",
"      Mattei P. Minimally invasive surgery in the diagnosis and treatment of abdominal pain in children. Curr Opin Pediatr 2007; 19:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/32\">",
"      Akkoyun I, G&uuml;len S. Laparoscopic cystectomy for the treatment of benign ovarian cysts in children: an analysis of 21 cases. J Pediatr Adolesc Gynecol 2012; 25:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/33\">",
"      Cohen SB, Oelsner G, Seidman DS, et al. Laparoscopic detorsion allows sparing of the twisted ischemic adnexa. J Am Assoc Gynecol Laparosc 1999; 6:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/34\">",
"      Pansky M, Abargil A, Dreazen E, et al. Conservative management of adnexal torsion in premenarchal girls. J Am Assoc Gynecol Laparosc 2000; 7:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/35\">",
"      Aziz D, Davis V, Allen L, Langer JC. Ovarian torsion in children: is oophorectomy necessary? J Pediatr Surg 2004; 39:750.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/36\">",
"      Laufer MR, Billet A, Diller L, et al. A new technique for laparoscopic prophylactic oophoropexy prior to craniospinal irradiation in children with medulloblastoma. Adolesc Pediatr Gynecol 1995; 8:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/37\">",
"      Cass DL, Hawkins E, Brandt ML, et al. Surgery for ovarian masses in infants, children, and adolescents: 102 consecutive patients treated in a 15-year period. J Pediatr Surg 2001; 36:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/38\">",
"      Holt VL, Cushing-Haugen KL, Daling JR. Oral contraceptives, tubal sterilization, and functional ovarian cyst risk. Obstet Gynecol 2003; 102:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/39\">",
"      Lipitz S, Seidman DS, Menczer J, et al. Recurrence rate after fluid aspiration from sonographically benign-appearing ovarian cysts. J Reprod Med 1992; 37:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/40\">",
"      Goldstein DP, deCholnoky C, Emans SJ, Leventhal JM. Laparoscopy in the diagnosis and management of pelvic pain in adolescents. J Reprod Med 1980; 24:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/41\">",
"      Reddy J, Laufer MR. Advantage of conservative surgical management of large ovarian neoplasms in adolescents. Fertil Steril 2009; 91:1941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/42\">",
"      Oltmann SC, Garcia N, Barber R, et al. Can we preoperatively risk stratify ovarian masses for malignancy? J Pediatr Surg 2010; 45:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/43\">",
"      Brown MF, Hebra A, McGeehin K, Ross AJ 3rd. Ovarian masses in children: a review of 91 cases of malignant and benign masses. J Pediatr Surg 1993; 28:930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/44\">",
"      You W, Dainty LA, Rose GS, et al. Gynecologic malignancies in women aged less than 25 years. Obstet Gynecol 2005; 105:1405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/45\">",
"      Hassan E, Creatsas G, Deligeorolgou E, Michalas S. Ovarian tumors during childhood and adolescence. A clinicopathological study. Eur J Gynaecol Oncol 1999; 20:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/46\">",
"      Schultz KA, Sencer SF, Messinger Y, et al. Pediatric ovarian tumors: a review of 67 cases. Pediatr Blood Cancer 2005; 44:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21033/abstract/47\">",
"      Haddad LB, Laufer MR. Thrombocytosis associated with malignant ovarian lesions within a pediatric/adolescent population. J Pediatr Adolesc Gynecol 2008; 21:243.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5909 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.55.141.10-E9920BD3B2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_34_21033=[""].join("\n");
var outline_f20_34_21033=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H34\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      OVARIAN CYSTS IN THE FETUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Management and outcome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      OVARIAN CYSTS IN NEONATES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Ovarian torsion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Overview",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Serial ultrasound",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Aspiration",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Surgical excision",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Outcome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      OVARIAN CYSTS IN INFANTS AND PREPUBERTAL CHILDREN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Etiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Management and outcome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      OVARIAN CYSTS IN ADOLESCENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Clinical features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Management and outcome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Follicular cysts",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Corpus luteum cysts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      OVARIAN CANCER",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Tumor markers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Staging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5909\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5909|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?21/38/22113\" title=\"diagnostic image 1\">",
"      Fetal ovarian cyst",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5909|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/51/42815\" title=\"picture 1\">",
"      Cafe au lait spots",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5909|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/41/1693\" title=\"table 1\">",
"      Sex cord stromal tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?7/5/7259\" title=\"table 2\">",
"      Complication fetal ovarian cyst",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?14/43/15038\" title=\"table 3\">",
"      Staging ovarian peritoneal carcinoma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/3/32826?source=related_link\">",
"      Acute appendicitis in children: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/0/1032?source=related_link\">",
"      Clinical features and diagnosis of pelvic inflammatory disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/9/1178?source=related_link\">",
"      Clinical manifestations, diagnosis, and management of ectopic pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/5/19546?source=related_link\">",
"      Definition, etiology, and evaluation of precocious puberty",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/11/12473?source=related_link\">",
"      Diagnosis and management of congenital anomalies of the vagina",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/57/19352?source=related_link\">",
"      Differential diagnosis of the adnexal mass",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/17/6426?source=related_link\">",
"      Epidemiology, clinical manifestations, diagnosis, and natural history of uterine leiomyomas (fibroids)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/6/31849?source=related_link\">",
"      Epithelial carcinoma of the ovary, fallopian tube, and peritoneum: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/48/36618?source=related_link\">",
"      Epithelial ovarian cancer: Initial surgical management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/52/17224?source=related_link\">",
"      Epithelial ovarian cancer: Pathology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/6/12393?source=related_link\">",
"      Oophorectomy and ovarian cystectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/8/23690?source=related_link\">",
"      Ovarian and fallopian tube torsion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/37/5721?source=related_link\">",
"      Ovarian germ cell neoplasms: Pathology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/40/34440?source=related_link\">",
"      Sonographic differentiation of benign versus malignant adnexal masses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/24/33162?source=related_link\">",
"      Treatment of malignant germ cell tumors of the ovary",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/49/4889?source=related_link\">",
"      Treatment of precocious puberty",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f20_34_21034="Cutaneous manifestations of tuberculosis";
var content_f20_34_21034=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Cutaneous manifestations of tuberculosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/34/21034/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/34/21034/contributors\">",
"     Evangeline B Handog, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/34/21034/contributors\">",
"     Maria Juliet E Macarayo, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/34/21034/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/34/21034/contributors\">",
"     Ted Rosen, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/34/21034/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/34/21034/contributors\">",
"     Abena O Ofori, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?20/34/21034/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 10, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H494561\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tuberculosis (TB) is a mycobacterial infection that most frequently occurs due to infection with",
"    <em>",
"     Mycobacterium tuberculosis",
"    </em>",
"    , an acid-fast bacillus. The high prevalence of TB worldwide (one-third of the world population), its transmissible nature, and the significant morbidity and mortality associated with this infection account for the status of TB as a major public health concern [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/13/18649?source=see_link&amp;anchor=H2#H2\">",
"     \"Epidemiology of tuberculosis\", section on 'Global burden'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cutaneous lesions are relatively uncommon manifestations of TB, occurring in only 1 to 2 percent of infected patients. The clinical findings vary; inflammatory papules, verrucous plaques, suppurative nodules, chronic ulcers, or other lesions may be seen. Factors such as the pathway of bacterial entry into the skin, the host&rsquo;s immune status, and the presence or absence of host sensitization to",
"    <em>",
"     M. tuberculosis",
"    </em>",
"    influence the presentation of TB in the skin.",
"   </p>",
"   <p>",
"    The cutaneous disorders associated with TB will be reviewed here. The epidemiology and microbiology of TB, extracutaneous TB, and the general principles of the treatment of TB are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/13/18649?source=see_link\">",
"     \"Epidemiology of tuberculosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/54/22378?source=see_link\">",
"     \"Microbiology and pathogenesis of tuberculosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/21/19802?source=see_link\">",
"     \"Treatment of pulmonary tuberculosis in HIV-negative patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22503288\">",
"    <span class=\"h1\">",
"     HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cutaneous TB was first documented in 1826, when Laennec reported his own \"prosector's wart,\" a lesion that likely represented tuberculosis verrucosa cutis, a variant of TB that results from direct entry of the organism into the skin [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/2\">",
"     2",
"    </a>",
"    ]. However, the causative organism of TB was unknown until Robert Koch discovered",
"    <em>",
"     Mycobacterium tuberculosis",
"    </em>",
"    in 1882 [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/3\">",
"     3",
"    </a>",
"    ]. Subsequently, the bacillus was detected in cutaneous lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H22503353\">",
"     'Clinical variants'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H494532\">",
"    <span class=\"h1\">",
"     GENERAL PRINCIPLES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cutaneous TB is a relatively uncommon manifestation of TB, accounting for only 1 to 2 percent of all cases [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. Similar to other forms of TB, a resurgence of cutaneous TB has been noted in parts of the world where human immunodeficiency virus (HIV) infection and multidrug-resistant TB are prevalent [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/8-10\">",
"     8-10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/13/18649?source=see_link&amp;anchor=H2#H2\">",
"     \"Epidemiology of tuberculosis\", section on 'Global burden'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H605174\">",
"    <span class=\"h2\">",
"     Etiologic agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;TB is defined as a disorder caused by mycobacteria in the",
"    <em>",
"     Mycobacterium tuberculosis",
"    </em>",
"    complex, which includes",
"    <em>",
"     M. tuberculosis",
"    </em>",
"    ,",
"    <em>",
"     M. bovis",
"    </em>",
"    ,",
"    <em>",
"     M. africanum",
"    </em>",
"    ,",
"    <em>",
"     M. microti",
"    </em>",
"    ,",
"    <em>",
"     M. canetti",
"    </em>",
"    ,",
"    <em>",
"     M. caprae",
"    </em>",
"    , and",
"    <em>",
"     M",
"    </em>",
"    .",
"    <em>",
"     pinnipedii",
"    </em>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/11\">",
"     11",
"    </a>",
"    ].",
"    <em>",
"     M. tuberculosis",
"    </em>",
"    , a slow-growing acid-fast bacillus, is the predominant causative organism of cutaneous TB.",
"    <em>",
"     M. bovis",
"    </em>",
"    and the Bacille Calmette-Gu&eacute;rin (BCG) vaccine (a vaccine composed of attenuated",
"    <em>",
"     M. bovis",
"    </em>",
"    ), have also been associated with the development of cutaneous lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/54/22378?source=see_link&amp;anchor=H2#H2\">",
"     \"Microbiology and pathogenesis of tuberculosis\", section on 'Microbiology'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/14/16614?source=see_link\">",
"     \"Mycobacterium bovis\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H3763980\">",
"     'BCG vaccination reactions'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H494648\">",
"    <span class=\"h2\">",
"     Classification",
"    </span>",
"    &nbsp;&mdash;&nbsp;The multiple disorders classified as manifestations of TB differ not only according to the clinical appearance of lesions, but also by the method of skin infection, the quantity of organisms in the skin, and predisposing factors, such as a patient&rsquo;s age, immune competence, and TB sensitization status [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/8,13\">",
"     8,13",
"    </a>",
"    ]. The method of infection is the characteristic most often used to subdivide the disorders. Although most cases arise from contiguous spread or hematogenous dissemination to the skin from an endogenous focus of infection, direct entry of",
"    <em>",
"     M. tuberculosis",
"    </em>",
"    into the skin occasionally results in local infection [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/8,10\">",
"     8,10",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H22503353\">",
"     'Clinical variants'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The classification of the variants of TB according to the mode of infection is as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Inoculation from an exogenous source",
"      </strong>",
"      (see",
"      <a class=\"local\" href=\"#H2020187\">",
"       'Exogenous inoculation'",
"      </a>",
"      below)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Primary inoculation TB &nbsp;",
"     </li>",
"     <li>",
"      Tuberculosis verrucosa cutis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Endogenous spread by contiguous extension or autoinoculation",
"      </strong>",
"      (see",
"      <a class=\"local\" href=\"#H2020211\">",
"       'Contiguous spread'",
"      </a>",
"      below)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Scrofuloderma",
"     </li>",
"     <li>",
"      Tuberculosis cutis orificialis",
"     </li>",
"     <li>",
"      Lupus vulgaris",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Hematogenous spread to the skin",
"      </strong>",
"      (see",
"      <a class=\"local\" href=\"#H2729176\">",
"       'Hematogenous spread'",
"      </a>",
"      below)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Lupus vulgaris",
"     </li>",
"     <li>",
"      Acute miliary TB",
"     </li>",
"     <li>",
"      Metastatic tuberculous abscess",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The disorders that comprise cutaneous TB may also be divided according to the bacterial load in the skin [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/7\">",
"     7",
"    </a>",
"    ].",
"    <strong>",
"     Multibacillary",
"    </strong>",
"    forms (bacilli easily detectable in tissue or exudate) include primary inoculation TB, scrofuloderma, tuberculosis cutis orificialis, acute miliary TB, and metastatic tuberculous abscess. The",
"    <strong>",
"     paucibacillary",
"    </strong>",
"    forms of cutaneous TB include tuberculosis verrucosa cutis and lupus vulgaris.",
"   </p>",
"   <p>",
"    The",
"    <strong>",
"     tuberculids",
"    </strong>",
"    are a separate category of TB-associated cutaneous disorders that likely represent hypersensitivity reactions to mycobacterial antigens, rather than manifestations of local skin infection. The disorders included in the category of tuberculids include papulonecrotic tuberculid, lichen scrofulosorum, and erythema induratum of Bazin. (See",
"    <a class=\"local\" href=\"#H22503411\">",
"     'Tuberculids'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22503325\">",
"    <span class=\"h2\">",
"     Host factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;As mentioned above, the likelihood for specific cutaneous manifestations of",
"    <em>",
"     M. tuberculosis",
"    </em>",
"    infection varies based upon multiple host characteristics, such as age, sex, and health status. As examples, primary inoculation TB, scrofuloderma, and lichen scrofulosorum commonly affect children, and females are more likely than males to develop lupus vulgaris and erythema induratum of Bazin. In addition, the presence of poor immunity against",
"    <em>",
"     M. tuberculosis",
"    </em>",
"    is a risk factor for tuberculosis cutis orificialis, metastatic tuberculous abscess, and acute miliary TB [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/3,8\">",
"     3,8",
"    </a>",
"    ]. Higher levels of immunity against",
"    <em>",
"     M. tuberculosis",
"    </em>",
"    are linked with tuberculosis verrucosa cutis, lupus vulgaris, and tuberculids [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H22503353\">",
"     'Clinical variants'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22503346\">",
"    <span class=\"h2\">",
"     Histopathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;A characteristic histopathologic finding in cutaneous TB is the",
"    <strong>",
"     tuberculoid granuloma",
"    </strong>",
"    , an accumulation of epithelioid histiocytes and Langhans-type giant cells that demonstrates a variable degree of central caseation necrosis and a peripheral rim composed of numerous lymphocytes (",
"    <a class=\"graphic graphic_picture graphicRef74597 \" href=\"UTD.htm?35/45/36560\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/9,14\">",
"     9,14",
"    </a>",
"    ]. Although tuberculoid granulomas are a common finding in cutaneous TB, their detection does not confirm the presence of TB, and their absence does not exclude the diagnosis. Leprosy, syphilis, granulomatous rosacea, leishmaniasis, deep fungal infections, and other disorders may also present with tuberculoid granulomas [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/9,15,16\">",
"     9,15,16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The classic granulomas of sarcoidosis differ from tuberculoid granulomas. Compared with tuberculoid granulomas, sarcoidal granulomas tend to be more circumscribed, exhibit fewer peripheral inflammatory cells (naked granulomas), and are less likely to have central caseation necrosis (",
"    <a class=\"graphic graphic_picture graphicRef80383 graphicRef54204 \" href=\"UTD.htm?36/36/37450\">",
"     picture 2A-B",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/20/19786?source=see_link&amp;anchor=H245206#H245206\">",
"     \"Cutaneous manifestations of sarcoidosis\", section on 'Histopathology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H494576\">",
"    <span class=\"h2\">",
"     Diagnostic tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Similar to extracutaneous TB, multiple diagnostic studies are utilized for the evaluation of patients with cutaneous TB. The conventional techniques include mycobacterial culture (the gold standard for diagnosis), stained smears, lesional biopsies, and tuberculin skin testing. However, in paucibacillary variants, culture, smears, and histopathology often fail to detect the presence of",
"    <em>",
"     M. tuberculosis",
"    </em>",
"    due to the relatively low number of organisms in lesional tissue. Such tests also are not typically useful for the diagnosis of tuberculids, in which mycobacteria generally are not detected in skin lesions. The",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/35/15924?source=see_link\">",
"     tuberculin skin test",
"    </a>",
"    can be positive in both multibacillary and paucibacillary forms of cutaneous TB; however, a positive test only identifies individuals who have been sensitized to TB and does not confirm active TB infection. &nbsp;",
"   </p>",
"   <p>",
"    Newer techniques that have been developed for the evaluation of patients with suspected TB include interferon-gamma release assays, which, like the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/35/15924?source=see_link\">",
"     tuberculin skin test",
"    </a>",
"    , identify patients who have been exposed to",
"    <em>",
"     M. tuberculosis",
"    </em>",
"    , and nucleic amplification tests (eg, polymerase chain reaction) that identify mycobacterial DNA in lesional tissue. The role that these newer techniques should play in the diagnosis of cutaneous TB remains uncertain. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/56/9098?source=see_link\">",
"     \"Diagnosis of pulmonary tuberculosis in HIV-negative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/46/12009?source=see_link\">",
"     \"Diagnosis of latent tuberculosis infection in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/10/20648?source=see_link\">",
"     \"Diagnosis of latent tuberculosis infection in HIV-negative adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/18/37160?source=see_link\">",
"     \"Interferon-gamma release assays for diagnosis of latent tuberculosis infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Mycobacterial culture",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      Mycobacterial culture",
"      <strong>",
"      </strong>",
"      is the gold standard for determining the presence of active TB infection. The procedure also provides the means to distinguish",
"      <em>",
"       M. tuberculosis",
"      </em>",
"      form nontuberculous mycobacteria and allows for the determination of antibiotic sensitivity [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/5,8\">",
"       5,8",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/56/9098?source=see_link&amp;anchor=H13#H13\">",
"       \"Diagnosis of pulmonary tuberculosis in HIV-negative patients\", section on 'Diagnostic microbiology'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/56/9098?source=see_link&amp;anchor=H4856569#H4856569\">",
"       \"Diagnosis of pulmonary tuberculosis in HIV-negative patients\", section on 'Culture'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Stained smear",
"      </strong>",
"      &ndash; The examination for acid-fast bacilli on a stained smear is a more rapid diagnostic technique than culture. The diagnostic yield of stained smears is highest for moist or exudative lesions that have a high bacterial load such as primary inoculation TB, scrofuloderma, tuberculosis cutis orificialis, or metastatic tuberculous abscess. The Ziehl-Neelsen acid-fast stain is the most commonly used stain for this purpose. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/56/9098?source=see_link&amp;anchor=H14#H14\">",
"       \"Diagnosis of pulmonary tuberculosis in HIV-negative patients\", section on 'Stained smears'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Skin biopsy",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      The accessibility of skin lesions makes the obtainment of a tissue biopsy a relatively simple procedure. The identification of tuberculoid granulomas, acid-fast bacilli, or other characteristic histopathologic features of specific variants of cutaneous TB may be used to support the diagnosis. (See",
"      <a class=\"local\" href=\"#H22503346\">",
"       'Histopathology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/35/15924?source=see_link\">",
"       Tuberculin skin test",
"      </a>",
"      &ndash; The tuberculin skin test identifies individuals sensitized to",
"      <em>",
"       M. tuberculosis",
"      </em>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/5,17\">",
"       5,17",
"      </a>",
"      ]. The Mantoux technique, the recommended method for performing tuberculin skin testing, involves the injection of tuberculin material (purified protein derivative [PPD]) into the inner surface of the forearm, followed by reexamination of the injection site 48 to 72 hours later (",
"      <a class=\"graphic graphic_table graphicRef67357 \" href=\"UTD.htm?31/0/31756\">",
"       table 1",
"      </a>",
"      ). The test becomes positive 2 to 10 weeks following infection [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/5\">",
"       5",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/10/20648?source=see_link&amp;anchor=H6#H6\">",
"       \"Diagnosis of latent tuberculosis infection in HIV-negative adults\", section on 'Tuberculin skin test'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/53/13143?source=see_link&amp;anchor=H7#H7\">",
"       \"Latent tuberculosis infection in children\", section on 'Tuberculin skin test'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Reactivity to the tuberculin protein may be impaired in young infants, the elderly, and patients with deficient cellular immunity (",
"      <a class=\"graphic graphic_table graphicRef58908 \" href=\"UTD.htm?8/46/8940\">",
"       table 2",
"      </a>",
"      ). In addition, the likelihood of a positive tuberculin skin test varies among the different subtypes of cutaneous TB. (See",
"      <a class=\"local\" href=\"#H22503353\">",
"       'Clinical variants'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      <strong>",
"       Interferon-gamma release assay",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      Interferon-gamma release assays are serologic tests that assess for latent TB infection via the measurement of interferon-gamma production from peripheral blood mononuclear cells after exposure to antigens from",
"      <em>",
"       M. tuberculosis",
"      </em>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/15,17\">",
"       15,17",
"      </a>",
"      ]. According to guidelines from the United States Centers for Disease Control, interferon-gamma release assays are an acceptable alternative to tuberculin skin tests [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/18\">",
"       18",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/18/37160?source=see_link\">",
"       \"Interferon-gamma release assays for diagnosis of latent tuberculosis infection\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Unlike the",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/35/15924?source=see_link\">",
"       tuberculin skin test",
"      </a>",
"      , the bacille Calmette-Gu&eacute;rin (BCG) vaccination does not influence the results of this test. However, prior infections with select environmental mycobacteria, such as",
"      <em>",
"       M. marinum",
"      </em>",
"      and",
"      <em>",
"       M. kansasii",
"      </em>",
"      , may result in a false positive interferon-gamma release assay.",
"     </li>",
"     <li>",
"      <strong>",
"       Polymerase chain reaction",
"      </strong>",
"      &ndash; Polymerase chain reaction (PCR) testing for",
"      <em>",
"       M. tuberculosis",
"      </em>",
"      infection involves the use of nucleic amplification for the detection of",
"      <em>",
"       M. tuberculosis",
"      </em>",
"      DNA in tissue specimens. PCR appears to be the most useful in the multibacillary forms of cutaneous TB [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/19-21\">",
"       19-21",
"      </a>",
"      ]. Although PCR may be positive in paucibacillary disease when both cultures and histopathologic stains for the organism are negative, the results of testing are inconsistent [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/20,22-25\">",
"       20,22-25",
"      </a>",
"      ]. In addition, the availability of PCR in developing countries is limited [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/20,23,26\">",
"       20,23,26",
"      </a>",
"      ]. PCR is primarily used as an adjunct to clinicopathologic evaluation [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/15\">",
"       15",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/56/9098?source=see_link&amp;anchor=H4856355#H4856355\">",
"       \"Diagnosis of pulmonary tuberculosis in HIV-negative patients\", section on 'Molecular tests'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Therapeutic trial",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      A therapeutic trial of anti-TB medications may be used to confirm the diagnosis of TB in difficult cases.",
"      <strong>",
"      </strong>",
"      In cutaneous TB, a response to multidrug therapy is usually evident within six weeks [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/26,27\">",
"       26,27",
"      </a>",
"      ]. With the exception of tuberculids and some patients with minimal clinical activity prior to treatment, the diagnosis should be reevaluated in patients who fail to improve within this period [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/27\">",
"       27",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H606441\">",
"       'Treatment overview'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H721004\">",
"    <span class=\"h2\">",
"     Evaluation for extracutaneous involvement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with lesions consistent with variants of cutaneous TB that result from the spread of the bacillus from endogenous foci of infection should be evaluated for the primary site of infection [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/28\">",
"     28",
"    </a>",
"    ]. The evaluation for extracutaneous TB is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/56/9098?source=see_link\">",
"     \"Diagnosis of pulmonary tuberculosis in HIV-negative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/10/1194?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of tuberculosis in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/4/23625?source=see_link&amp;anchor=H9#H9\">",
"     \"Tuberculosis disease in children\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22503353\">",
"    <span class=\"h1\">",
"     CLINICAL VARIANTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical variants of cutaneous TB may be divided into infections acquired through exogenous inoculation, infections that result from contiguous spread, infections related to hematogenous dissemination, and the tuberculids. The tuberculids are thought to be hypersensitivity reactions to",
"    <em>",
"     M. tuberculosis",
"    </em>",
"    , and include papulonecrotic tuberculid, lichen scrofulosorum, and erythema induratum of Bazin. (See",
"    <a class=\"local\" href=\"#H22503411\">",
"     'Tuberculids'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2020187\">",
"    <span class=\"h2\">",
"     Exogenous inoculation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary inoculation TB and tuberculosis verrucosa cutis represent the variants of cutaneous TB that are acquired through the inoculation of the organism into the skin. Primary inoculation TB occurs in individuals who have not previously been sensitized to",
"    <em>",
"     M. tuberculosis",
"    </em>",
"    , whereas tuberculosis verrucosa cutis develops in individuals with prior exposure to the bacterium.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22503362\">",
"    <span class=\"h3\">",
"     Primary inoculation tuberculosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary inoculation TB (also known as tuberculous chancre and primary tuberculous complex) is",
"    <strong>",
"    </strong>",
"    a rare form of cutaneous TB that results from the direct entry of the organism into the skin or mucosa of a nonsensitized individual. The disorder primarily occurs in children in endemic areas [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/3\">",
"     3",
"    </a>",
"    ]. Minor trauma resulting in a comprised skin barrier usually precedes the infection. Surgical procedures performed with unsterilized equipment may also lead to lesion development [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Clinical features",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      Primary inoculation TB becomes clinically evident within one month after inoculation. Classically, the lesion begins as a nondescript red-brown papule or nodule that evolves into a painless, shallow and undermined ulcer with a granulomatous base. Lesions are usually 1 cm or less in diameter, but occasionally exceed 5 cm [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/3\">",
"       3",
"      </a>",
"      ]. The face and extremities are the most common sites for lesion development.",
"      <br/>",
"      <br/>",
"      Slowly progressive and painless regional lymphadenopathy frequently becomes apparent three to eight weeks after the appearance of the skin lesion. Occasionally, lymph node involvement results in perforation of the skin and the development of draining sinuses [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/3,19\">",
"       3,19",
"      </a>",
"      ]. The combination of the cutaneous findings and lymphadenopathy in primary inoculation TB are analogous to the Ghon complex of pulmonary TB infection [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/7\">",
"       7",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/54/22378?source=see_link&amp;anchor=H13826076#H13826076\">",
"       \"Microbiology and pathogenesis of tuberculosis\", section on 'Primary disease'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Diagnosis",
"      </strong>",
"      &ndash; Early primary inoculation TB is multibacillary, and acid-fast bacilli (AFB) are usually easily detected in smears taken from early lesions [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/9,30,31\">",
"       9,30,31",
"      </a>",
"      ]. A positive culture confirms the diagnosis. As immunity develops, the number of bacteria present in the lesions decreases [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/9\">",
"       9",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Skin biopsies obtained early in the disease course reveal necrosis, neutrophilic infiltrates, and numerous acid-fast bacilli [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/3\">",
"       3",
"      </a>",
"      ]. In contrast, lesions that have been present for several weeks or longer demonstrate tuberculoid granulomas with or without caseation necrosis, and few or no bacilli [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/30,32\">",
"       30,32",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H22503346\">",
"       'Histopathology'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      The",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/35/15924?source=see_link\">",
"       tuberculin skin test",
"      </a>",
"      is negative at the time of disease onset, but becomes positive with disease progression and resolution [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/9,33\">",
"       9,33",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Differential diagnosis",
"      </strong>",
"      &ndash; The differential diagnosis of primary inoculation TB includes other infections that may present with inflammatory nodules or ulcers, including deep fungal infections, nocardiosis, syphilis, leishmaniasis, yaws, tularemia, bartonellosis, cat-scratch disease, and other mycobacterioses [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/5,9,31\">",
"       5,9,31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Disease course",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      Left untreated, primary inoculation TB may persist for up to one year [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/3\">",
"       3",
"      </a>",
"      ]. A scar typically remains after resolution. Patients become sensitized to TB as a consequence of infection. (See",
"      <a class=\"local\" href=\"#H606441\">",
"       'Treatment overview'",
"      </a>",
"      below.)",
"      <br/>",
"      <br/>",
"      A potential complication of primary inoculation TB is hematogenous spread of the bacillus leading to TB of other organs or acute miliary disease [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/9\">",
"       9",
"      </a>",
"      ]. Moreover, erythema nodosum occurs in approximately 10 percent of cases, and occasionally lupus vulgaris or scrofuloderma develops at the site of a lesion [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/3\">",
"       3",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/21/20826?source=see_link\">",
"       \"Clinical manifestations, diagnosis, and treatment of extrapulmonary and miliary tuberculosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/52/13130?source=see_link\">",
"       \"Erythema nodosum\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22503369\">",
"    <span class=\"h3\">",
"     Tuberculosis verrucosa cutis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tuberculosis verrucosa cutis (TBVC, also known as prosector&rsquo;s wart, anatomic tuberculosis, verruca necrogenica, and warty tuberculosis) is",
"    <strong>",
"    </strong>",
"    a form of cutaneous TB that occurs after direct inoculation of the mycobacteria into the skin of a previously sensitized host with moderate to high immunity against the bacillus [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/5,8,9,19\">",
"     5,8,9,19",
"    </a>",
"    ]. Inoculation typically occurs from an exogenous source; rarely inoculation may occur from the patient&rsquo;s own sputum [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/12\">",
"     12",
"    </a>",
"    ].",
"    <br/>",
"    <br/>",
"    Children who play in contaminated areas and adults with occupational exposure to mycobacteria (eg, pathologists, laboratory technicians, undertakers, butchers, and farmers) are at greatest risk for this infection [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/3,34\">",
"     3,34",
"    </a>",
"    ]. TBVC is much more common than the primary inoculation variant [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Clinical features",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      In adults, TBVC most frequently develops on the acral extremities; the fingers and dorsum of the hands are commonly affected [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/3,5,13,15,34,35\">",
"       3,5,13,15,34,35",
"      </a>",
"      ]. The ankles or buttocks are frequent sites for lesion occurrence in children [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/5\">",
"       5",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The skin lesions are usually solitary and manifest as painless, violaceous or brown-red, indurated warty plaques that range from 1 to 5 cm in diameter (",
"      <a class=\"graphic graphic_picture graphicRef81731 \" href=\"UTD.htm?35/33/36382\">",
"       picture 3",
"      </a>",
"      ). TBVC grows via peripheral extension; central clearing and atrophy may or may not be present [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/5\">",
"       5",
"      </a>",
"      ]. Although ulceration is uncommon, fissures that exude purulent drainage or keratinous material may occur [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/3,12\">",
"       3,12",
"      </a>",
"      ]. Other potential clinical findings include regional adenopathy in patients with secondary bacterial infection and lymphostasis and elephantiasis of affected extremities in patients with extensive and chronic involvement [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/12,13\">",
"       12,13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Diagnosis",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      The histopathologic findings of TBVC include pseudoepitheliomatous hyperplasia, marked hyperkeratosis, and microabscesses in the superficial dermis or the pseudoepitheliomatous rete pegs (",
"      <a class=\"graphic graphic_picture graphicRef59116 \" href=\"UTD.htm?8/39/8824\">",
"       picture 4",
"      </a>",
"      ). An inflammatory infiltrate composed of epithelioid cells and giant cells is usually present in the upper and middle dermis. Frank tuberculoid granulomas may or may not be evident [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/3,9,32\">",
"       3,9,32",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Although a few acid-fast bacilli can be detected on careful histopathologic examination in some cases [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/3,12,32\">",
"       3,12,32",
"      </a>",
"      ], cultures taken from lesions of TBVC are often negative [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/5,9,19\">",
"       5,9,19",
"      </a>",
"      ]. The",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/35/15924?source=see_link\">",
"       tuberculin skin test",
"      </a>",
"      is strongly positive, indicative of the high level of immunity against the bacterium in affected patients [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/5,31\">",
"       5,31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Differential diagnosis",
"      </strong>",
"      &ndash; Other disorders to be considered in patients with lesions suggestive of TBVC include diseases that may present with hyperkeratotic or verrucous plaques, including atypical mycobacterioses, blastomycosis, Majocchi&rsquo;s granuloma, chromoblastomycosis, tertiary syphilis, verrucous epidermal nevus, hypertrophic lichen planus, lupus vulgaris, halogenoderma, benign keratoses, and verruca vulgaris [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/5,9,31\">",
"       5,9,31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Disease course",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      Skin lesions may persist for years if left untreated, although spontaneous resolution can also occur [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/8,9,19,31\">",
"       8,9,19,31",
"      </a>",
"      ]. Patients typically improve with anti-TB therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/19\">",
"       19",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H606441\">",
"       'Treatment overview'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2020211\">",
"    <span class=\"h2\">",
"     Contiguous spread",
"    </span>",
"    &nbsp;&mdash;&nbsp;TB infection can be transmitted to the skin from adjacent structures. Scrofuloderma, tuberculosis cutis orificialis, and lupus vulgaris can occur as a result of this process.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22503376\">",
"    <span class=\"h3\">",
"     Scrofuloderma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Scrofuloderma",
"    <strong>",
"    </strong>",
"    (also known as tuberculosis colliquativa cutis) is a form of cutaneous TB that occurred much more frequently prior to the advent of effective therapies for TB. This disorder results from the direct extension of the infection from a deep structure (eg, lymph node, bone, joint, or epididymis) into the overlying skin [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/19,29\">",
"     19,29",
"    </a>",
"    ]. Scrofuloderma may occur at any age, but most commonly develops in children, adolescents, and elderly individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/9,13,19,31\">",
"     9,13,19,31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to",
"    <em>",
"     M. tuberculosis",
"    </em>",
"    infection,",
"    <em>",
"     M. bovis",
"    </em>",
"    infection related to the consumption of contaminated milk may lead to scrofuloderma [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/36\">",
"     36",
"    </a>",
"    ]. The occurrence of scrofuloderma following bacille Calmette-Gu&eacute;rin (BCG) vaccination has also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/37\">",
"     37",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/14/16614?source=see_link\">",
"     \"Mycobacterium bovis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/12/40136?source=see_link\">",
"     \"BCG vaccination\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Clinical features",
"      </strong>",
"      &ndash; Early lesions of scrofuloderma are firm, painless, subcutaneous, red-brown nodules that overly foci of tuberculous infection. The neck, axillae, and groin are often involved, with the cervical lymph nodes as the most common source of infection [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/3,13\">",
"       3,13",
"      </a>",
"      ]. The suppurative nodules gradually enlarge, and eventually form ulcers and sinus tracts that drain watery, purulent, or caseous material (",
"      <a class=\"graphic graphic_picture graphicRef72008 \" href=\"UTD.htm?41/54/42862\">",
"       picture 5",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/12,19\">",
"       12,19",
"      </a>",
"      ]. Lesions may be single or multiple. A linear arrangement can occur if the infection overlies multiple lymph nodes within a region [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Diagnosis",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      The diagnosis of scrofuloderma is based upon the identification of the causative organism by culture, smear, or skin biopsy [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/12\">",
"       12",
"      </a>",
"      ]. Skin biopsy reveals tuberculoid granulomas surrounding areas of wedge-shaped necrosis [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/9,19\">",
"       9,19",
"      </a>",
"      ]. Tuberculin skin testing is positive [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/9,30\">",
"       9,30",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Differential diagnosis",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      Scrofuloderma must be differentiated from other causes of suppurative nodules, including atypical mycobacterioses, sporotrichosis, actinomycosis, coccidioidomycosis, lymphogranuloma venereum, syphilis, severe forms of acne conglobata, and hidradenitis suppurativa [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/5,9,31\">",
"       5,9,31",
"      </a>",
"      ]. In the neck, scrofuloderma may mimic a dental sinus.",
"     </li>",
"     <li>",
"      <strong>",
"       Disease course",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      Spontaneous healing may occur, but it may be years before lesions are completely replaced by scar tissue [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/12\">",
"       12",
"      </a>",
"      ]. Scars may be depressed, retractable, adherent, hypertrophic, or keloidal [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/9,13,19,30,31\">",
"       9,13,19,30,31",
"      </a>",
"      ]. Coexistence with an active pulmonary process is relatively common [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/13,31\">",
"       13,31",
"      </a>",
"      ]. In addition, lupus vulgaris may develop within or near sites of scrofuloderma [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/9\">",
"       9",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H22503390\">",
"       'Lupus vulgaris'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22503383\">",
"    <span class=\"h3\">",
"     Tuberculosis cutis orificialis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tuberculosis cutis orificialis (TBCO, also known as orificial tuberculosis and tuberculosis ulcerosa cutis et mucosae) is a rare manifestation of TB that most frequently occurs among middle-aged and elderly adults [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/31\">",
"     31",
"    </a>",
"    ]. TBCO develops in individuals with both advanced TB of the gastrointestinal tract, lungs, or genitourinary tract and dramatically impaired cell-mediated immunity [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/5,9,19\">",
"     5,9,19",
"    </a>",
"    ]. The skin lesions result from the autoinoculation of the mucocutaneous tissues near body orifices by the draining sites of visceral infection [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/12,15\">",
"     12,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Clinical features",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      TBCO occurs on the oral, nasal, or anogenital skin or mucosa [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/12,15\">",
"       12,15",
"      </a>",
"      ]. Among patients with oral involvement, the distal and lateral tongue are most frequently affected; lesions may also involve the palate, lips, or other sites [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/9,12\">",
"       9,12",
"      </a>",
"      ]. A typical lesion appears as a red-yellow nodule that rapidly breaks down to form a painful, circular or irregularly shaped, &ldquo;punched-out&rdquo; and friable 1 to 3 cm ulcer with a pseudomembranous fibrinous base (",
"      <a class=\"graphic graphic_picture graphicRef51950 \" href=\"UTD.htm?12/1/12304\">",
"       picture 6",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/5,8,9,12,31\">",
"       5,8,9,12,31",
"      </a>",
"      ]. Inflammation and edema are often present at the peripheral margins [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Diagnosis",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      The possibility of TBCO should be considered in patients with nonhealing periorificial ulcers and signs or symptoms suggestive of advanced TB [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/30\">",
"       30",
"      </a>",
"      ]. The detection of acid-fast bacilli in affected tissue via culture, stained smear, or skin biopsy confirms the diagnosis. Histopathologic examination of skin biopsies demonstrates easily detectable bacilli in the ulcer walls and tuberculoid granulomas at the ulcer edge and in the deep dermis [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/3,5,38\">",
"       3,5,38",
"      </a>",
"      ]. Cutaneous necrosis and intense nonspecific cellular infiltrates are also present [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/5,9,31\">",
"       5,9,31",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Tuberculin skin tests are often negative in patients with TBCO due to the associated impairment in host immunity. Because TBCO occurs as a consequence of visceral infection, the focus of active extracutaneous TB must be sought as part of the patient evaluation [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/13\">",
"       13",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/56/9098?source=see_link\">",
"       \"Diagnosis of pulmonary tuberculosis in HIV-negative patients\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/4/23625?source=see_link&amp;anchor=H9#H9\">",
"       \"Tuberculosis disease in children\", section on 'Diagnosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Differential diagnosis",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      Other causes of persistent periorificial ulcers should be considered during the evaluation of patients with suspected TBCO. Examples include aphthous ulcers, lymphogranuloma venereum, syphilis, and cutaneous malignancies [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/3,9,31\">",
"       3,9,31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Disease course",
"      </strong>",
"      &ndash; The presence of TBCO heralds a poor overall prognosis, as patients tend to have severe internal organ disease prior to skin manifestations [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/9,19\">",
"       9,19",
"      </a>",
"      ]. Without successful treatment of the TB infection, the lesions progress and may eventually contribute to the development of fatal miliary TB [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/39\">",
"       39",
"      </a>",
"      ]. Although resolution within two months after the initiation of treatment has been reported [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/39-41\">",
"       39-41",
"      </a>",
"      ], other cases may be recalcitrant to treatment [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22503390\">",
"    <span class=\"h3\">",
"     Lupus vulgaris",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lupus vulgaris (also known as tuberculosis lupus) is",
"    <strong>",
"    </strong>",
"    a chronic and progressive form of cutaneous TB that represents a reactivation of TB infection in people with moderate to high immunity against the bacillus [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/3,8\">",
"     3,8",
"    </a>",
"    ]. Lupus vulgaris may occur either as a result of direct extension from an underlying focus of infection or via lymphatic or hematogenous spread. The development of lupus vulgaris has also been reported in patients with prior scrofuloderma, and as a rare complication of BCG vaccination or primary inoculation TB [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/42-45\">",
"     42-45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This disorder is considered the most common form of cutaneous TB in Europe; scrofuloderma appears to be more prevalent in some tropical regions [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/7,46,47\">",
"     7,46,47",
"    </a>",
"    ]. Lupus vulgaris occurs in individuals of all ages. For unknown reasons, females are two to three times more likely than males to be affected [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Clinical features",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      The clinical findings of lupus vulgaris are variable. The classic plaque type of the disorder begins as a collection of discrete, red-brown papules that subsequently coalesce to form an indolent, asymptomatic plaque (",
"      <a class=\"graphic graphic_picture graphicRef64828 \" href=\"UTD.htm?1/5/1119\">",
"       picture 7",
"      </a>",
"      ). The plaque gradually grows peripherally to reach a size of 0.5 to 10 cm and develops central clearing and atrophy. The borders may acquire a serpiginous or verrucous quality. Hypertrophic, ulcerative, and vegetative forms of lupus vulgaris may also occur [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/12\">",
"       12",
"      </a>",
"      ]. Secondarily infected lesions may exhibit a seropurulent discharge and crusting.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The distribution of lesions is variable. In western countries, lesions often develop on the head and neck, while in tropical and subtropical areas, lesions are commonly found on the lower extremities or buttocks [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/19\">",
"     19",
"    </a>",
"    ].",
"    <br/>",
"    <br/>",
"    Similar to other granulomatous disorders such as sarcoidosis and leprosy, diascopy (examination of the lesion under compression with a glass slide) of non-hyperkeratotic areas of lupus vulgaris often reveals a yellow-brown color referred to as an &ldquo;apple jelly&rdquo; appearance [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/3\">",
"     3",
"    </a>",
"    ]. However, this finding can be difficult or impossible to appreciate in patients with dark skin [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Diagnosis",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      Lupus vulgaris is a paucibacillary form of cutaneous TB, and mycobacteria often cannot be detected histopathologically or by culture [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/12\">",
"       12",
"      </a>",
"      ]. Information that may be used to support the diagnosis includes consistent clinical and histopathologic features and positive PCR test results [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/48\">",
"       48",
"      </a>",
"      ]. Tuberculin skin testing is also often positive.",
"      <br/>",
"      <br/>",
"      Histopathologic examination reveals tuberculoid granulomas with discrete central caseation in the upper dermis [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/19,30,31\">",
"       19,30,31",
"      </a>",
"      ]. The epidermis may be atrophic or acanthotic with excessive hyperkeratosis or pseudoepitheliomatous hyperplasia (",
"      <a class=\"graphic graphic_picture graphicRef53074 \" href=\"UTD.htm?20/35/21055\">",
"       picture 8",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/5,9\">",
"       5,9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Differential diagnosis",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      Lupus vulgaris shares clinical features with multiple disorders [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/5,9,13,31\">",
"       5,9,13,31",
"      </a>",
"      ]. Papular lesions should be distinguished from colloid milia, acne, and rosacea. Plaques may resemble deep fungal infections, leishmaniasis, late syphilis, discoid lupus, lymphocytoma cutis, tuberculoid leprosy, and pyodermatitis vegetans. &nbsp;",
"     </li>",
"     <li>",
"      <strong>",
"       Disease course",
"      </strong>",
"      &ndash; If anti-TB therapy is not administered, lesions of lupus vulgaris persist. Over the course of years, the plaques may grow to enormous sizes. In addition, ulceration and destruction of underlying tissues such as the nose, ears, and lips, may occur, causing severe disfigurement [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/3,12\">",
"       3,12",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H606441\">",
"       'Treatment overview'",
"      </a>",
"      below.)",
"      <br/>",
"      <br/>",
"      Squamous cell carcinoma occasionally develops in long-standing lesions [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/48-51\">",
"       48-51",
"      </a>",
"      ]. The development of basal cell carcinoma and other cutaneous malignancies has also been reported [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/51\">",
"       51",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2729176\">",
"    <span class=\"h2\">",
"     Hematogenous spread",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hematogenous transmission of",
"    <em>",
"     M. tuberculosis",
"    </em>",
"    from a primary site of infection may lead to metastatic tuberculous abscesses (tuberculous gumma), acute miliary TB, or lupus vulgaris.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22503404\">",
"    <span class=\"h3\">",
"     Metastatic tuberculous abscesses (tuberculous gummas)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Metastatic tuberculous abscesses (also known as tuberculous gummas) usually arise as a consequence of hematogenous spread of the bacillus from a primary focus of infection to the subcutaneous tissue during a state of reduced cell-mediated immunity [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/12\">",
"     12",
"    </a>",
"    ]. These lesions typically occur in malnourished children and immunosuppressed adults [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/5,12,13\">",
"     5,12,13",
"    </a>",
"    ]. Immunocompetent adults are infrequently affected; such patients tend to have few lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Clinical features",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      Patients with metastatic tuberculous abscesses present with single or multiple, non-tender, fluctuant, subcutaneous nodules. The nodules eventually penetrate the skin resulting in the formation of ulcers and draining sinuses (",
"      <a class=\"graphic graphic_picture graphicRef65877 \" href=\"UTD.htm?40/16/41231\">",
"       picture 9",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/3\">",
"       3",
"      </a>",
"      ]. Lesions may occur at any skin site but frequently develop on the extremities [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/13\">",
"       13",
"      </a>",
"      ]. Associated regional adenopathy usually is not present [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Diagnosis",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      The diagnosis of metastatic tuberculous abscess is based upon the results of cultures, smears, or skin biopsies that demonstrate the presence of the bacillus. The histopathological examination is characterized by massive skin necrosis with numerous mycobacterial organisms and may also demonstrate tuberculoid granulomas in the deep dermis [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/3,5,19\">",
"       3,5,19",
"      </a>",
"      ]. The results of tuberculin skin testing are variable [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Differential diagnosis",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      Metastatic tuberculous abscesses share clinical and histological features with scrofuloderma. However, scrofuloderma occurs as a result of contiguous extension of an infection from an underlying tuberculous focus, rather than hematogenous dissemination [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/52\">",
"       52",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H22503376\">",
"       'Scrofuloderma'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <strong>",
"       Disease course",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      Metastatic tuberculous abscesses are a negative prognostic finding in malnourished and immunosuppressed individuals. Although lesions in immunocompetent individuals may persist for years if untreated, spontaneous resolution can eventually occur [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2729306\">",
"    <span class=\"h3\">",
"     Acute miliary tuberculosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute miliary TB (also known as tuberculosis cutis miliaris disseminata) is a rare form of TB that results from the hematogenous dissemination of mycobacteria from a primary focus of infection, such as the lung. The disorder typically occurs in infants or individuals with impaired cell-mediated immunity, such as patients with advanced acquired immune deficiency syndrome (AIDS) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most patients with acute miliary TB do not exhibit cutaneous lesions. When present, the cutaneous findings are nonspecific. Pinpoint red-blue or purpuric papules with overlying tiny vesicles that subsequently become umbilicated and crusted are typically seen. Individual lesions heal over the course of one to four weeks, and often resolve with hypopigmented depressed scars [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Skin biopsies can aid in the diagnosis of acute miliary TB in patients who present with cutaneous lesions. Numerous acid fast bacilli and abscesses are typically detected [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/12\">",
"     12",
"    </a>",
"    ]. Granulomas may be present in older lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/32\">",
"     32",
"    </a>",
"    ]. The",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/35/15924?source=see_link\">",
"     tuberculin skin test",
"    </a>",
"    is often negative due to associated anergy.",
"   </p>",
"   <p>",
"    Acute miliary tuberculosis is discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/21/20826?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and treatment of extrapulmonary and miliary tuberculosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3761763\">",
"    <span class=\"h3\">",
"     Lupus vulgaris",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to arising from contiguous spread, lupus vulgaris may also occur as a consequence of hematogenous dissemination of",
"    <em>",
"     M. tuberculosis",
"    </em>",
"    . Lupus vulgaris is discussed above. (See",
"    <a class=\"local\" href=\"#H22503390\">",
"     'Lupus vulgaris'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22503411\">",
"    <span class=\"h2\">",
"     Tuberculids",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of the disorders classified as tuberculids is not fully understood, but they are commonly considered to be cutaneous hypersensitivity eruptions to",
"    <em>",
"     M. tuberculosis",
"    </em>",
"    that occur in patients with a moderate or high levels of immunity against the organism [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/3,12,19\">",
"     3,12,19",
"    </a>",
"    ]. The three main tuberculid disorders are papulonecrotic tuberculid, lichen scrofulosorum, and erythema induratum of Bazin.",
"   </p>",
"   <p>",
"    The following findings support the designation of a condition as a tuberculid [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/3,5,19,30\">",
"     3,5,19,30",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Failure to detect",
"      <em>",
"       M. tuberculosis",
"      </em>",
"      in stains or cultures of affected tissue",
"     </li>",
"     <li>",
"      Presence of detectable extracutaneous",
"      <em>",
"       M. tuberculosis",
"      </em>",
"      infection, a strongly positive",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/35/15924?source=see_link\">",
"       tuberculin skin test",
"      </a>",
"      , or a positive interferon-gamma release assay (these findings support a history of exposure to the bacillus)",
"     </li>",
"     <li>",
"      Histopathologic evidence for granulomatous inflammation in skin lesions",
"     </li>",
"     <li>",
"      Frequent resolution of skin lesions with anti-TB therapy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although bacilli are usually not detectable in tuberculid lesions, DNA from",
"    <em>",
"     M. tuberculosis",
"    </em>",
"    has been detected, albeit inconsistently, in tissue specimens from papulonecrotic tuberculid and erythema induratum of Bazin [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. This finding offers some support for a role for",
"    <em>",
"     M. tuberculosis",
"    </em>",
"    in the pathogenesis of tuberculids.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22503418\">",
"    <span class=\"h3\">",
"     Papulonecrotic tuberculid (PNT)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Papulonecrotic tuberculid is the most common of the tuberculid disorders, and is most frequently seen in children and young adults [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Clinical features",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      Papulonecrotic tuberculid typically presents as a symmetric and recurring eruption of 2 to 8 mm, firm, dark red or violaceous papules that subsequently become pustular or necrotic (",
"      <a class=\"graphic graphic_picture graphicRef74606 graphicRef55062 \" href=\"UTD.htm?42/6/43105\">",
"       picture 10A-B",
"      </a>",
"      ). Lesions most commonly occur on the face, ears, extensor extremities, and buttocks [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/5,8,9,13,31\">",
"       5,8,9,13,31",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Fever and constitutional symptoms may precede the appearance of skin lesions [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/15,30\">",
"       15,30",
"      </a>",
"      ] and associated lymphadenitis is common [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Diagnosis",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      The diagnosis of papulonecrotic tuberculid is suggested by the presence of consistent clinical and histopathologic findings in a patient with risk factors for TB.",
"      <em>",
"      </em>",
"      Histopathologic examination often demonstrates wedge-shaped necrosis in the upper dermis and epidermis and nonspecific or tuberculoid granulomatous inflammation. Granulomatous vasculitis may also be present [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/5,9,55\">",
"       5,9,55",
"      </a>",
"      ].",
"      <em>",
"       M. tuberculosis",
"      </em>",
"      bacilli",
"      <em>",
"      </em>",
"      usually is not detectable via microscopy or cultures.",
"      <br/>",
"      <br/>",
"      In addition to the typical histopathologic findings, data that can support the diagnosis include a positive",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/35/15924?source=see_link\">",
"       tuberculin skin test",
"      </a>",
"      , a detectable extracutaneous focus of TB infection, the detection of mycobacterial DNA in lesional tissue [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/53,55,56\">",
"       53,55,56",
"      </a>",
"      ], and a positive response to anti-TB therapy. An extracutaneous focus of tuberculosis (eg, cervical lymph nodes, lungs, or other sites) is detectable in 38 to 75 percent of patients [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/57\">",
"       57",
"      </a>",
"      ]. In a series of 12 patients with papulonecrotic tuberculid, mycobacterial DNA was detected by PCR in 11 of 22 biopsy specimens [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/53\">",
"       53",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Differential diagnosis",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      The differential diagnosis of papulonecrotic tuberculid includes papular disorders that may present with necrotic or excoriated papules. Examples include pityriasis lichenoides et varioliformis acuta (PLEVA), prurigo, secondary syphilis, varicella, lymphomatoid papulosis, perforating disorders, leukocytoclastic vasculitis, and Churg-Strauss syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/5,9,31\">",
"       5,9,31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Clinical course",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      Although lesions may spontaneously resolve over the course of several weeks leaving residual pitted or varioliform scars, recurrence is common and if untreated, papulonecrotic tuberculid may persist for years [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/5,9,15,30,57\">",
"       5,9,15,30,57",
"      </a>",
"      ] . Patients typically improve within days to weeks of the initiation of anti-TB therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/56,58\">",
"       56,58",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H606441\">",
"       'Treatment overview'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22503425\">",
"    <span class=\"h3\">",
"     Lichen scrofulosorum",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lichen scrofulosorum is a rare tuberculid that most frequently occurs in children and young adults with nodal or skeletal TB [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/3,12,19\">",
"     3,12,19",
"    </a>",
"    ]. Lichen scrofulosorum has also been reported after BCG vaccination and in association with",
"    <em>",
"     M. avium-intracellulare",
"    </em>",
"    infection [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/59-62\">",
"     59-62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Clinical features",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      Lichen scrofulosorum presents with crops of firm 1 to 5 mm, asymptomatic, grouped, yellow-red to brown-red papules (",
"      <a class=\"graphic graphic_picture graphicRef63717 \" href=\"UTD.htm?23/53/24415\">",
"       picture 11",
"      </a>",
"      ). Lesions tend to be follicular or perifollicular, and are most often found on the trunk [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/3,9,15,30,31,63\">",
"       3,9,15,30,31,63",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Diagnosis",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      Similar to papulonecrotic tuberculid, the diagnosis of lichen scrofulosorum is based upon a consistent clinical picture in the context of concordant histopathologic findings and evidence for TB infection. The",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/35/15924?source=see_link\">",
"       tuberculin skin test",
"      </a>",
"      is often strongly positive [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/9,19\">",
"       9,19",
"      </a>",
"      ]. Mycobacterial cultures are negative [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/5,9\">",
"       5,9",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Histopathologic examination reveals tuberculoid granulomas in the upper dermis as well as around hair follicles and eccrine glands. Acid-fast bacilli are not detected [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/5,9,19\">",
"       5,9,19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Differential diagnosis",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      Other papular disorders may present with lesions that resemble lichen scrofulosorum. As examples, lichen planus, lichenoid secondary syphilis, papular eczema, lichen nitidus, and papular sarcoidosis should be considered in the differential diagnosis [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/5,9,31\">",
"       5,9,31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Clinical course",
"      </strong>",
"      &ndash; Without treatment, lesions spontaneously resolve without scarring after several months to several years [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/12\">",
"       12",
"      </a>",
"      ]. Anti-TB treatment usually leads to complete resolution within weeks [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/9\">",
"       9",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H606441\">",
"       'Treatment overview'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22503432\">",
"    <span class=\"h3\">",
"     Erythema induratum of Bazin",
"    </span>",
"    &nbsp;&mdash;&nbsp;The terms &ldquo;erythema induratum of Bazin&rdquo; (EIB) and &ldquo;nodular vasculitis&rdquo; are used to refer to a granulomatous lobular panniculitis of the lower extremities that may develop in association with a variety of disorders, particularly infections [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/54,64\">",
"     54,64",
"    </a>",
"    ]. Although the two terms are often used interchangeably to refer to this presentation, some authors have preferably utilized the term EIB to refer to TB-associated lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/54,65\">",
"     54,65",
"    </a>",
"    ]. Young women and middle-aged women are most commonly affected [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Clinical features",
"      </strong>",
"      &ndash; EIB classically presents with the development of mildly tender, dull red, subcutaneous nodules on the lower legs over the course of several weeks. The lesions are most commonly located on the posterior aspects of the lower legs and may be up to several centimeters in diameter [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/54,64\">",
"       54,64",
"      </a>",
"      ]. Break-down of the nodules often occurs, leading to the formation of deep, draining ulcers (",
"      <a class=\"graphic graphic_picture graphicRef76526 graphicRef53596 graphicRef64335 \" href=\"UTD.htm?39/34/40488\">",
"       picture 12A-C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      <strong>",
"       Diagnosis",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      The diagnosis of TB-associated EIB is made based upon recognition of the clinical features, histopathologic findings, and evidence for",
"      <em>",
"       M. tuberculosis",
"      </em>",
"      infection (eg, history of TB, a detectable focus of infection, a positive",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/35/15924?source=see_link\">",
"       tuberculin skin test",
"      </a>",
"      , or improvement with TB therapy) [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/54\">",
"       54",
"      </a>",
"      ]. Mycobacterial DNA can be detected by PCR in 14 to 77 percent of biopsy specimens [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/54\">",
"       54",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Since EIB is a form of panniculitis, a biopsy that obtains an adequate sample of the subcutaneous fat is essential for histopathological examination. An excisional wedge biopsy is the preferred procedure. The tissue specimen usually reveals a lobular or mixed lobular and septal panniculitis; tuberculoid or poorly formed granulomas; a mixed inflammatory infiltrate with neutrophils, lymphocytes, and plasma cells; and fat necrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/32\">",
"     32",
"    </a>",
"    ]. Vascular changes are also usually present; in some cases necrotizing vasculitis is seen. Acid-fast bacilli typically are not detected [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/3,19\">",
"     3,19",
"    </a>",
"    ].",
"    <br/>",
"    <br/>",
"    If an association with TB is not found in a patient with skin lesions consistent with this disorder, other potential causes of the eruption should be investigated. Hepatitis C is another disorder that may be a triggering factor for nodular",
"    <span class=\"nowrap\">",
"     vasculitis/EIB",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/54,66,67\">",
"     54,66,67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Differential diagnosis",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      Similar to EIB, nodules due to erythema nodosum primarily occur on the lower legs. However, in contrast to EIB, lesions of erythema nodosum are more likely to occur on the anterior legs and demonstrate a septal panniculitis on histopathologic examination. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/52/13130?source=see_link\">",
"       \"Erythema nodosum\"",
"      </a>",
"      .) Other disorders to consider include polyarteritis nodosa, tertiary syphilis, and other panniculitides [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Clinical course",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      The course of EIB is chronic. Although individual lesions spontaneously resolve over the course of several weeks to a few months, leaving scars and postinflammatory hyperpigmentation [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/64\">",
"       64",
"      </a>",
"      ], recurrences may occur every three to four months [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/54\">",
"       54",
"      </a>",
"      ]. Treatment with anti-TB agents is recommended for patients with evidence for TB-associated disease [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/54,64\">",
"       54,64",
"      </a>",
"      ]. Other agents that have been used for the management of",
"      <span class=\"nowrap\">",
"       EIB/nodular",
"      </span>",
"      vasculitis, include",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/27/30134?source=see_link\">",
"       potassium iodide",
"      </a>",
"      , nonsteroidal antiinflammatory agents,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/59/32688?source=see_link\">",
"       dapsone",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/13/32983?source=see_link\">",
"       colchicine",
"      </a>",
"      , antimalarials, tetracyclines, gold salts, and systemic glucocorticoids [",
"      <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/54\">",
"       54",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3763762\">",
"    <span class=\"h3\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nodular tuberculid is a more recently described tuberculid disorder that has been reported in several patients [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/68,69\">",
"     68,69",
"    </a>",
"    ]. Similar to EIB, patients present with nodules on the lower legs. However, in contrast to EIB, granulomatous inflammation occurs at the junction of the dermis and subcutaneous fat, rather than primarily within the panniculus. In addition, the lesions do not tend to ulcerate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H606441\">",
"    <span class=\"h1\">",
"     TREATMENT OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of cutaneous TB is the same as that for systemic TB. The administration of a course of multidrug therapy is the treatment of choice [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/5,8,15,19,30,70\">",
"     5,8,15,19,30,70",
"    </a>",
"    ]. An initial bactericidal phase given for eight weeks to induce a rapid reduction in the number of bacteria is followed by a longer treatment phase designed to eradicate any remaining bacteria [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/3,12,71\">",
"     3,12,71",
"    </a>",
"    ]. The choice of a specific regimen is influenced by patient comorbidities and immune status, as well as mycobacterial resistance patterns. Every effort should be made to culture the organism for sensitivity testing. Drug treatment regimens for TB are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/21/19802?source=see_link\">",
"     \"Treatment of pulmonary tuberculosis in HIV-negative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/35/19002?source=see_link\">",
"     \"Treatment of pulmonary tuberculosis in the HIV-infected patient\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/4/23625?source=see_link&amp;anchor=H20#H20\">",
"     \"Tuberculosis disease in children\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The response to treatment of cutaneous lesions can be assessed clinically. In general, treatment should be continued for at least two months following the complete resolution of skin lesions.",
"   </p>",
"   <p>",
"    Surgical intervention is not routinely utilized for the management of cutaneous TB, but is sometimes employed as an adjunct to pharmacologic therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/9\">",
"     9",
"    </a>",
"    ]. Surgical excision has been utilized to aid in the management of extensive or recalcitrant scrofuloderma. In addition, surgical excision, cauterization, and cryosurgery have been performed to hasten the resolution of small, early lesions of TBVC and lupus vulgaris. Reconstructive plastic surgery after treatment can be beneficial for patients with destructive lesions of lupus vulgaris [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/9,15\">",
"     9,15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3763973\">",
"    <span class=\"h1\">",
"     ASSOCIATED DISORDERS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3763980\">",
"    <span class=\"h2\">",
"     BCG vaccination reactions",
"    </span>",
"    &nbsp;&mdash;&nbsp;The bacille Calmette-Gu&eacute;rin (BCG) vaccine is composed of a living attenuated strain of",
"    <em>",
"     M. bovis",
"    </em>",
"    that is used in many parts of the world to enhance immunity to TB. Rarely, dermatologic complications of BCG vaccination occur. Local tissue reactions, ulceration, abscess formation, scrofuloderma, lupus vulgaris, EIB, papulonecrotic tuberculid, and lichen scrofulosorum-like lesions have been described [",
"    <a class=\"abstract\" href=\"UTD.htm?20/34/21034/abstract/5,59,72\">",
"     5,59,72",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/12/40136?source=see_link&amp;anchor=H12#H12\">",
"     \"BCG vaccination\", section on 'Safety and adverse effects'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3764525\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tuberculosis (TB) is a mycobacterial infection that can affect multiple organ systems.",
"      <em>",
"       M. tuberculosis",
"      </em>",
"      , an acid-fast bacillus, is the primary inciting organism of cutaneous TB. (See",
"      <a class=\"local\" href=\"#H494532\">",
"       'General principles'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cutaneous TB may result from direct entry of the mycobacterium into the skin or from local or hematogenous spread of",
"      <em>",
"       M. tuberculosis",
"      </em>",
"      from an endogenous focus. The immune response of the host to",
"      <em>",
"       M. tuberculosis",
"      </em>",
"      is an important factor in the development of cutaneous TB. (See",
"      <a class=\"local\" href=\"#H494532\">",
"       'General principles'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H22503353\">",
"       'Clinical variants'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A variety of diagnostic studies are used for the evaluation of patients with suspected cutaneous TB. Mycobacterial cultures represent the gold standard for confirming active infection. Other studies that may be utilized for patient evaluation include stained smears, histopathologic evaluation, tuberculin skin tests, interferon-gamma release assays, and nucleic acid amplification tests. (See",
"      <a class=\"local\" href=\"#H494576\">",
"       'Diagnostic tests'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The tuberculids are a group of cutaneous disorders that may reflect hypersensitivity reactions to",
"      <em>",
"       M. tuberculosis",
"      </em>",
"      antigens. The three main subtypes of tuberculids are papulonecrotic tuberculid, lichen scrofulosorum, and erythema induratum of Bazin. Organisms usually are not detectable in cultures, smears, or pathology specimens taken from tuberculid skin lesions. (See",
"      <a class=\"local\" href=\"#H22503411\">",
"       'Tuberculids'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Systemic treatment with multidrug therapy is the cornerstone of treatment of cutaneous TB.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/1\">",
"      L&ouml;nnroth K, Raviglione M. Global epidemiology of tuberculosis: prospects for control. Semin Respir Crit Care Med 2008; 29:481.",
"     </a>",
"    </li>",
"    <li>",
"     Laennec RT. Traite de l&rsquo;auscultation mediate et des maladies des peumons et du coeur, Asselin and Cie, Paris 1826. p.649.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/3\">",
"      MacGregor RR. Cutaneous tuberculosis. Clin Dermatol 1995; 13:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/4\">",
"      MICHELSON HE. The history of lupus vulgaris. J Invest Dermatol 1946; 7:261.",
"     </a>",
"    </li>",
"    <li>",
"     James WD, Berger TG, Elston DM. Andrews' Diseases of the Skin Clinical Dermatology, 11th ed, Elsevier, 2011. p.322.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/6\">",
"      Rai VM, Shenoi SD. Tuberculous gluteal abscess coexisting with scrofuloderma and tubercular lymphadenitis. Dermatol Online J 2005; 11:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/7\">",
"      Bravo FG, Gotuzzo E. Cutaneous tuberculosis. Clin Dermatol 2007; 25:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/8\">",
"      Handog EB, Gabriel TG, Pineda RT. Management of cutaneous tuberculosis. Dermatol Ther 2008; 21:154.",
"     </a>",
"    </li>",
"    <li>",
"     Tappeiner G. Tuberculosis and infections with atypical mycobacteria. In: Fitzparick's Dermatology in General Medicine, 7th ed, Wolff K, Goldsmith LA, Katz SI, et al (Eds), McGraw Hill Medical, New York 2008. p.1768.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/10\">",
"      Gopinathan R, Pandit D, Joshi J, et al. Clinical and morphological variants of cutaneous tuberculosis and its relation to Mycobacterium species. Indian J Med Microbiol 2001; 19:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/11\">",
"      van Soolingen D, Hoogenboezem T, de Haas PE, et al. A novel pathogenic taxon of the Mycobacterium tuberculosis complex, Canetti: characterization of an exceptional isolate from Africa. Int J Syst Bacteriol 1997; 47:1236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/12\">",
"      Barbagallo J, Tager P, Ingleton R, et al. Cutaneous tuberculosis: diagnosis and treatment. Am J Clin Dermatol 2002; 3:319.",
"     </a>",
"    </li>",
"    <li>",
"     Arenas R. Cutaneous tuberculosis. In: Tropical Dermatology, Arenas R, Estrada R (Eds), Landes Bioscience, Georgetown, TX 2001. p.132.",
"    </li>",
"    <li>",
"     Khanna N. Illustrated Synopsis of Dermatology and Sexually Transmitted Diseases, 3rd ed, Elsevier, India 2009. p.217.",
"    </li>",
"    <li>",
"     Handog EB, Ramam M, Gabriel MTG, Suthar C. Skin tuberculosis in South Asia. In: Asian Skin and Skin Diseases, Eun HC, Kim, S-C, Lee WS (Eds), MEDrang Inc, Korea 2011. p.349.",
"    </li>",
"    <li>",
"     Weedon D. Cutaneous infections and infestations - histological patterns. In: Weedon's Skin Pathology, 3rd ed, Elsevier Limited, 2010. p.544.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/17\">",
"      Regatieri A, Abdelwahed Y, Perez MT, Bush LM. Testing for tuberculosis: the roles of tuberculin skin tests and interferon gamma release assays. Lab Investigation 2011; 42:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/18\">",
"      Mazurek GH, Jereb J, Vernon A, et al. Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep 2010; 59:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/19\">",
"      Frankel A, Penrose C, Emer J. Cutaneous tuberculosis: a practical case report and review for the dermatologist. J Clin Aesthet Dermatol 2009; 2:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/20\">",
"      Tan SH, Tan BH, Goh CL, et al. Detection of Mycobacterium tuberculosis DNA using polymerase chain reaction in cutaneous tuberculosis and tuberculids. Int J Dermatol 1999; 38:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/21\">",
"      Pai M. The accuracy and reliability of nucleic acid amplification tests in the diagnosis of tuberculosis. Natl Med J India 2004; 17:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/22\">",
"      Tan SH, Tan HH, Sun YJ, Goh CL. Clinical utility of polymerase chain reaction in the detection of Mycobacterium tuberculosis in different types of cutaneous tuberculosis and tuberculids. Ann Acad Med Singapore 2001; 30:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/23\">",
"      Hsiao PF, Tzen CY, Chen HC, Su HY. Polymerase chain reaction based detection of Mycobacterium tuberculosis in tissues showing granulomatous inflammation without demonstrable acid-fast bacilli. Int J Dermatol 2003; 42:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/24\">",
"      Arora SK, Kumar B, Sehgal S. Development of a polymerase chain reaction dot-blotting system for detecting cutaneous tuberculosis. Br J Dermatol 2000; 142:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/25\">",
"      Padmavathy L, Rao L, Veliath A. Utility of polymerase chain reaction as a diagnostic tool in cutaneous tuberculosis. Indian J Dermatol Venereol Leprol 2003; 69:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/26\">",
"      Ramam M, Mittal R, Ramesh V. How soon does cutaneous tuberculosis respond to treatment? Implications for a therapeutic test of diagnosis. Int J Dermatol 2005; 44:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/27\">",
"      Ramam M, Tejasvi T, Manchanda Y, et al. What is the appropriate duration of a therapeutic trial in cutaneous tuberculosis? Further observations. Indian J Dermatol Venereol Leprol 2007; 73:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/28\">",
"      Pandhi D, Reddy BS, Chowdhary S, Khurana N. Cutaneous tuberculosis in Indian children: the importance of screening for involvement of internal organs. J Eur Acad Dermatol Venereol 2004; 18:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/29\">",
"      Sehgal VN. Cutaneous tuberculosis. Dermatol Clin 1994; 12:645.",
"     </a>",
"    </li>",
"    <li>",
"     Ramam M. Cutaneous tuberculosis. In: Tuberculosis, 2nd ed, Sharma SK, Mohan A (Eds), Jaypee Brothers, New Delhi 2009. p.384.",
"    </li>",
"    <li>",
"     Nascimento LV. Tuberculosis. In: Tropical Dermatology, Tyring SK, Lupi O, Hengge UR (Eds), Churchill Livingstone, London 2005. p.251.",
"    </li>",
"    <li>",
"     Weedon D. Bacterial and rickettsial infections. In: Weedon's Skin Pathology, 3rd, Elsevier Limited, 2010. p.547.",
"    </li>",
"    <li>",
"     Nascimento LV, Neves RG. Tuberculose cutanea. In: Dermatologia Tropical, Talhart S, Neves RG (Eds), MEDSI, Rio de Janeiro 1995. p.267.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/34\">",
"      Sehgal VN, Sehgal R, Bajaj P, et al. Tuberculosis verrucosa cutis (TBVC). J Eur Acad Dermatol Venereol 2000; 14:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/35\">",
"      Gruber PC, Whittam LR, du Vivier A. Tuberculosis verrucosa cutis on the sole of the foot. Clin Exp Dermatol 2002; 27:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/36\">",
"      M&uuml;ller H, Eisendle K, Zelger B, Zangerle R. Bilateral scrofuloderma of the axilla masquerading as hidradenitis suppurativa. Acta Derm Venereol 2008; 88:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/37\">",
"      Tan H, Karakuzu A, Arik A. Scrofuloderma after BCG vaccination. Pediatr Dermatol 2002; 19:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/38\">",
"      Brown FS, Anderson RH, Burnett JW. Cutaneous tuberculosis. J Am Acad Dermatol 1982; 6:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/39\">",
"      Leon-Mateos A, S&aacute;nchez-Aguilar D, Lado F, Toribio J. Perianal ulceration: a case of tuberculosis cutis orificialis. J Eur Acad Dermatol Venereol 2005; 19:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/40\">",
"      Choi SR, Kim JK, Kim DH, Yoon MS. A case of tuberculosis cutis orificialis with perianal involvement. Ann Dermatol 2009; 21:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/41\">",
"      Yueh LH, Loo LY, Hoon TS, Hee TH. Persistent perianal ulcers. Tuberculosis cutis orificialis (TCO). Arch Dermatol 2009; 145:931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/42\">",
"      Marcoval J, Servitje O, Moreno A, et al. Lupus vulgaris. Clinical, histopathologic, and bacteriologic study of 10 cases. J Am Acad Dermatol 1992; 26:404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/43\">",
"      HORWITZ O, MEYER J. The safety record of BCG vaccination and untoward reactions observed after vaccination. Bibl Tuberc 1957; 13:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/44\">",
"      HARTSTON W. Uncommon skin reactions after BCG vaccination. Tubercle 1959; 40:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/45\">",
"      Fari&ntilde;a MC, Gegundez MI, Piqu&eacute; E, et al. Cutaneous tuberculosis: a clinical, histopathologic, and bacteriologic study. J Am Acad Dermatol 1995; 33:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/46\">",
"      Kumar B, Muralidhar S. Cutaneous tuberculosis: a twenty-year prospective study. Int J Tuberc Lung Dis 1999; 3:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/47\">",
"      Kivan&ccedil;-Altunay I, Baysal Z, Ekmek&ccedil;i TR, K&ouml;sl&uuml; A. Incidence of cutaneous tuberculosis in patients with organ tuberculosis. Int J Dermatol 2003; 42:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/48\">",
"      Ljubenovic MS, Ljubenovic DB, Binic II, et al. Cutaneous tuberculosis and squamous-cell carcinoma. An Bras Dermatol 2011; 86:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/49\">",
"      Motswaledi MH, Doman C. Lupus vulgaris with squamous cell carcinoma. J Cutan Pathol 2007; 34:939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/50\">",
"      Zawirska A, Adamski Z, Stawicka E, Schwartz RA. Cutaneous squamous cell carcinoma developing in lupus vulgaris exfoliativus persistent for 40 years. Int J Dermatol 2009; 48:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/51\">",
"      Kanitakis J, Audeffray D, Claudy A. Squamous cell carcinoma of the skin complicating lupus vulgaris. J Eur Acad Dermatol Venereol 2006; 20:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/52\">",
"      Almagro M, Del Pozo J, Rodr&iacute;guez-Lozano J, et al. Metastatic tuberculous abscesses in an immunocompetent patient. Clin Exp Dermatol 2005; 30:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/53\">",
"      Victor T, Jordaan HF, Van Niekerk DJ, et al. Papulonecrotic tuberculid. Identification of Mycobacterium tuberculosis DNA by polymerase chain reaction. Am J Dermatopathol 1992; 14:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/54\">",
"      Mascar&oacute; JM Jr, Baselga E. Erythema induratum of bazin. Dermatol Clin 2008; 26:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/55\">",
"      Wong S, Rizvi H, Cerio R, O'Toole EA. An unusual case of vulval papulonecrotic tuberculid. Clin Exp Dermatol 2011; 36:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/56\">",
"      Jordaan HF, Schneider JW, Schaaf HS, et al. Papulonecrotic tuberculid in children. A report of eight patients. Am J Dermatopathol 1996; 18:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/57\">",
"      Freiman A, Ting P, Miller M, Greenaway C. Papulonecrotic tuberculid: a rare form of cutaneous tuberculosis. Cutis 2005; 75:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/58\">",
"      Jordaan HF, Van Niekerk DJ, Louw M. Papulonecrotic tuberculid. A clinical, histopathological, and immunohistochemical study of 15 patients. Am J Dermatopathol 1994; 16:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/59\">",
"      Park YM, Kang H, Cho SH, Cho BK. Lichen scrofulosorum-like eruption localized to multipuncture BCG vaccination site. J Am Acad Dermatol 1999; 41:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/60\">",
"      Tobita R, Sumikawa Y, Imaoka K, et al. Lichen scrofulosorum caused by pulmonary Mycobacterium avium complex (MAC) infection. Eur J Dermatol 2011; 21:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/61\">",
"      Komatsu H, Terunuma A, Tabata N, Tagami H. Mycobacterium avium infection of the skin associated with lichen scrofulosorum: report of three cases. Br J Dermatol 1999; 141:554.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/62\">",
"      Jacobsen G, Samolitis NJ, Harris RM. Lichenoid eruption in a patient with AIDS--lichen scrofulosorum (LS) tuberculid with underlying MAC infection. Arch Dermatol 2006; 142:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/63\">",
"      Sehgal VN, Srivastava G, Khurana VK, et al. An appraisal of epidemiologic, clinical, bacteriologic, histopathologic, and immunologic parameters in cutaneous tuberculosis. Int J Dermatol 1987; 26:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/64\">",
"      Gilchrist H, Patterson JW. Erythema nodosum and erythema induratum (nodular vasculitis): diagnosis and management. Dermatol Ther 2010; 23:320.",
"     </a>",
"    </li>",
"    <li>",
"     Requena L, Yus ES, Kutzner H. Panniculitis. In: Fitzpatrick's Dermatology in General Medicine, 7th ed, Wolff K, Goldsmith LA, Katz SI, et al.  (Eds), McGraw Hill, 2008. Vol 1, p.569.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/66\">",
"      Ural I, Erel A, Ozenirler S, et al. Nodular vasculitis associated with chronic hepatitis C. J Eur Acad Dermatol Venereol 2002; 16:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/67\">",
"      Cardinali C, Gerlini G, Caproni M, et al. Hepatitis C virus: a common triggering factor for both nodular vasculitis and Sj&ouml;gren's syndrome? Br J Dermatol 2000; 142:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/68\">",
"      Friedman PC, Husain S, Grossman ME. Nodular tuberculid in a patient with HIV. J Am Acad Dermatol 2005; 53:S154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/69\">",
"      Jordaan HF, Schneider JW, Abdulla EA. Nodular tuberculid: a report of four patients. Pediatr Dermatol 2000; 17:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/70\">",
"      Sethuraman G, Ramesh V, Ramam M, Sharma VK. Skin tuberculosis in children: learning from India. Dermatol Clin 2008; 26:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/71\">",
"      Blomberg B, Fourie B. Fixed-dose combination drugs for tuberculosis: application in standardised treatment regimens. Drugs 2003; 63:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/34/21034/abstract/72\">",
"      Dostrowsky A, et al. Dermatologic complications of BCG vaccination. Br J Dermatol 1963; 75:181.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15866 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-203.80.222.8-E8883B2495-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_34_21034=[""].join("\n");
var outline_f20_34_21034=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H3764525\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H494561\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22503288\">",
"      HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H494532\">",
"      GENERAL PRINCIPLES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H605174\">",
"      Etiologic agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H494648\">",
"      Classification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22503325\">",
"      Host factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22503346\">",
"      Histopathology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H494576\">",
"      Diagnostic tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H721004\">",
"      Evaluation for extracutaneous involvement",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22503353\">",
"      CLINICAL VARIANTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2020187\">",
"      Exogenous inoculation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22503362\">",
"      - Primary inoculation tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22503369\">",
"      - Tuberculosis verrucosa cutis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2020211\">",
"      Contiguous spread",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22503376\">",
"      - Scrofuloderma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22503383\">",
"      - Tuberculosis cutis orificialis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22503390\">",
"      - Lupus vulgaris",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2729176\">",
"      Hematogenous spread",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22503404\">",
"      - Metastatic tuberculous abscesses (tuberculous gummas)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2729306\">",
"      - Acute miliary tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3761763\">",
"      - Lupus vulgaris",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22503411\">",
"      Tuberculids",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22503418\">",
"      - Papulonecrotic tuberculid (PNT)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22503425\">",
"      - Lichen scrofulosorum",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22503432\">",
"      - Erythema induratum of Bazin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3763762\">",
"      - Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H606441\">",
"      TREATMENT OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3763973\">",
"      ASSOCIATED DISORDERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3763980\">",
"      BCG vaccination reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3764525\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/15866\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/15866|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?35/45/36560\" title=\"picture 1\">",
"      Tuberculoid granuloma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?3/41/3736\" title=\"picture 2A\">",
"      Cutaneous sarcoidosis - histopathology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/63/1017\" title=\"picture 2B\">",
"      Cutaneous sarcoidosis - histopathology high power",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?35/33/36382\" title=\"picture 3\">",
"      Tuberculosis verrucosa cutis on knee",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?8/39/8824\" title=\"picture 4\">",
"      Tuberculosis verrucosa cutis histopathology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/54/42862\" title=\"picture 5\">",
"      Scrofuloderma ulcer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?12/1/12304\" title=\"picture 6\">",
"      Tuberculosis cutis orificialis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?1/5/1119\" title=\"picture 7\">",
"      Lupus vulgaris papule",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?20/35/21055\" title=\"picture 8\">",
"      Lupus vulgaris histopathology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?40/16/41231\" title=\"picture 9\">",
"      Metastatic tuberculous abscesses",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?19/29/19935\" title=\"picture 10A\">",
"      Papulonecrotic tuberculid on extremities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/54/35694\" title=\"picture 10B\">",
"      Papulonecrotic tuberculid on penis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?23/53/24415\" title=\"picture 11\">",
"      Lichen scrofulosorum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/30/42479\" title=\"picture 12A\">",
"      Erythema induratum of Bazin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?28/6/28768\" title=\"picture 12B\">",
"      Erythema induratum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/62/44002\" title=\"picture 12C\">",
"      Erythema induratum 2",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/15866|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?31/0/31756\" title=\"table 1\">",
"      Tuberculin skin test interpretation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?8/46/8940\" title=\"table 2\">",
"      Causes of false negative TST",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/12/40136?source=related_link\">",
"      BCG vaccination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/21/20826?source=related_link\">",
"      Clinical manifestations, diagnosis, and treatment of extrapulmonary and miliary tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/20/19786?source=related_link\">",
"      Cutaneous manifestations of sarcoidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/46/12009?source=related_link\">",
"      Diagnosis of latent tuberculosis infection in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/10/20648?source=related_link\">",
"      Diagnosis of latent tuberculosis infection in HIV-negative adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/56/9098?source=related_link\">",
"      Diagnosis of pulmonary tuberculosis in HIV-negative patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/13/18649?source=related_link\">",
"      Epidemiology of tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/10/1194?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of tuberculosis in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/52/13130?source=related_link\">",
"      Erythema nodosum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/18/37160?source=related_link\">",
"      Interferon-gamma release assays for diagnosis of latent tuberculosis infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/53/13143?source=related_link\">",
"      Latent tuberculosis infection in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/54/22378?source=related_link\">",
"      Microbiology and pathogenesis of tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/14/16614?source=related_link\">",
"      Mycobacterium bovis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/21/19802?source=related_link\">",
"      Treatment of pulmonary tuberculosis in HIV-negative patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/35/19002?source=related_link\">",
"      Treatment of pulmonary tuberculosis in the HIV-infected patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/4/23625?source=related_link\">",
"      Tuberculosis disease in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f20_34_21035="Clinical features sIgMD";
var content_f20_34_21035=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F67168&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F67168&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical features of selective IgM deficiency",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Primary presentation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sepsis and bacteremia (gram negative bacteria, encapsulated pathogens)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diarrhea",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dermatitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Frequent upper respiratory infections",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Meningitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Other reported presentations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Elevated IgE",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Allergic disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chronic idiopathic/immune thrombocytopenic purpura",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Large warts (Epidermodysplasia verruciformis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Splenomegaly",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Growth retardation in children",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Possible presentations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Autoimmunity (increased response to self antigens?)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_34_21035=[""].join("\n");
var outline_f20_34_21035=null;
var title_f20_34_21036="Causes of erythema multiforme";
var content_f20_34_21036=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F72248&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F72248&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of erythema multiforme",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Contact reactions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tadania ignis (fire sponge)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Drugs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Allopurinol",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Antituberculous agents",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Barbiturates",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Carbamazepine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Oral hypoglycemic agents",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        NSAIDs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Phenytoin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sulfonamides",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Endocrine factors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pregnancy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Idiopathic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &gt;50 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Infections",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Epstein-Barr virus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Francisella tularensis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemolytic streptococci",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Herpes simplex 1 and 2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Histoplasma capsulatum",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mycoplasma pneumoniae",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mycobacterium tuberculosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Proteus sp",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Salmonella sp",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Staphylococcus sp",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vibrio parahaemolyticus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Yersinia sp",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Physical",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sunlight",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        X-ray therapy",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission from Sanders CV, Diagnosis of the Patient&nbsp;with Fever and Rash. In: The Skin and Infection: A Color Atlas and&nbsp;Text, Sanders, CV, Nesbitt, LT (Eds), Williams &amp; Wilkins, Baltimore, 1995. Originally modified with permission from Dermatology in General Medicine, Fitzpatrick, TB et al (Eds), McGraw-Hill, New York, 1993.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_34_21036=[""].join("\n");
var outline_f20_34_21036=null;
var title_f20_34_21037="Stage group testicular CA";
var content_f20_34_21037=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F56341&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F56341&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    TNM anatomic stage/prognostic groups for testicular cancer",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Stage",
"       </td>",
"       <td class=\"subtitle1\">",
"        Primary tumor (T)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Regional lymph nodes (N)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Distant metastasis (M)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Serum tumor markers (S)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        pTis",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        S0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        I",
"       </td>",
"       <td>",
"        pT1-4",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        SX",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IA",
"       </td>",
"       <td>",
"        pT1",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        S0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        IB",
"       </td>",
"       <td>",
"        pT2",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        S0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        pT3",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        S0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        pT4",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        S0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IS",
"       </td>",
"       <td>",
"        Any pT/Tx",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        S1-3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        II",
"       </td>",
"       <td>",
"        Any pT/Tx",
"       </td>",
"       <td>",
"        N1-3",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        SX",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        IIA",
"       </td>",
"       <td>",
"        Any pT/Tx",
"       </td>",
"       <td>",
"        N1",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        S0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Any pT/Tx",
"       </td>",
"       <td>",
"        N1",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        S1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        IIB",
"       </td>",
"       <td>",
"        Any pT/Tx",
"       </td>",
"       <td>",
"        N2",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        S0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Any pT/Tx",
"       </td>",
"       <td>",
"        N2",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        S1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        IIC",
"       </td>",
"       <td>",
"        Any pT/Tx",
"       </td>",
"       <td>",
"        N3",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        S0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Any pT/Tx",
"       </td>",
"       <td>",
"        N3",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        S1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        III",
"       </td>",
"       <td>",
"        Any pT/Tx",
"       </td>",
"       <td>",
"        Any N",
"       </td>",
"       <td>",
"        M1",
"       </td>",
"       <td>",
"        SX",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        IIIA",
"       </td>",
"       <td>",
"        Any pT/Tx",
"       </td>",
"       <td>",
"        Any N",
"       </td>",
"       <td>",
"        M1a",
"       </td>",
"       <td>",
"        S0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Any pT/Tx",
"       </td>",
"       <td>",
"        Any N",
"       </td>",
"       <td>",
"        M1a",
"       </td>",
"       <td>",
"        S1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        IIIB",
"       </td>",
"       <td>",
"        Any pT/Tx",
"       </td>",
"       <td>",
"        N1-3",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        S2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Any pT/Tx",
"       </td>",
"       <td>",
"        Any N",
"       </td>",
"       <td>",
"        M1a",
"       </td>",
"       <td>",
"        S2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        IIIC",
"       </td>",
"       <td>",
"        Any pT/Tx",
"       </td>",
"       <td>",
"        N1-3",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        S3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Any pT/Tx",
"       </td>",
"       <td>",
"        Any N",
"       </td>",
"       <td>",
"        M1a",
"       </td>",
"       <td>",
"        S3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Any pT/Tx",
"       </td>",
"       <td>",
"        Any N",
"       </td>",
"       <td>",
"        M1b",
"       </td>",
"       <td>",
"        Any S",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Note: pTNM is the pathologic staging classification.",
"    <div class=\"footnotes\">",
"     Tx: primary tumor cannot be assessed.",
"    </div>",
"    <div class=\"reference\">",
"     Used with the permission of the American Joint Committee on Cancer (AJCC), Chicago, Illinois. The original source for this material is the AJCC Cancer Staging Manual, Seventh Edition (2010) published by Springer New York, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_34_21037=[""].join("\n");
var outline_f20_34_21037=null;
var title_f20_34_21038="Histo dx test sensitivity";
var content_f20_34_21038=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F56766&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F56766&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 538px\">",
"   <div class=\"ttl\">",
"    Overview of serology and antigen tests in acute pulmonary histoplasmosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 518px; height: 280px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Histoplasma capsulatum antigen (Ag) can be detected in patients with acute pulmonary histoplasmosis and is found more commonly in patients with severe clinical manifestations. Detection of high titers of complement fixing antibodies to the yeast or mycelia antigen precedes detection of M or H bands by immunodiffusion in most patients. However, antibodies rarely appear before the fourth week of infection and often do not reach maximal titers until the second or third month of infection.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Joseph Wheat, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_34_21038=[""].join("\n");
var outline_f20_34_21038=null;
var title_f20_34_21039="Incisional hernia";
var content_f20_34_21039=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F66840&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F66840&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Incisional hernia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 313px; height: 335px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An incisional hernia occurs when bowel protrudes through a defect or weakness resulting from a surgical incision. It appears as a bulge near a surgical scar on the abdomen.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Weber, J, Kelley, J. Health Assessment in Nursing, Second Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_34_21039=[""].join("\n");
var outline_f20_34_21039=null;
